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Fructose-1,6-bisphosphate (FBP) aldolase links
sensing of declining glucose availability toAMPKacti-
vation via the lysosomal pathway. However, how
aldolase transmits lack of occupancy by FBP to
AMPK activation remains unclear. Here, we show
that FBP-unoccupied aldolase interacts with and in-
hibits endoplasmic reticulum (ER)-localized transient
receptor potential channel subfamily V, inhibiting cal-
cium release in low glucose. The decrease of calcium
at contact sites between ER and lysosome renders
the inhibited TRPV accessible to bind the lysosomal
v-ATPase that then recruits AXIN:LKB1 to activate
AMPK independently of AMP. Genetic depletion of
TRPVs blocks glucose starvation-induced AMPK
activation in cells and liver of mice, and in nematodes,
indicative of physical requirement of TRPVs. Pharma-
cological inhibition of TRPVs activates AMPK andContext and Significance
Cells contain an internal energy sensor called AMP-activated p
and energy levels by activating cellular pathways to replenish
dissect the molecular pathways underlying AMPK activation in
another important cellular pathway, through transient receptor
is evolutionarily conserved, and TRPV seems to act as an electr
aging and decreased muscular fitness is associated with decr
cally increase AMPK levels in aged muscles, something that
treated aged mice doubled their running capacity.
508 Cell Metabolism 30, 508–524, September 3, 2019 ª 2019 The Au
This is an open access article under the CC BY license (http://creativeelevates NAD+ levels in aged muscles, rejuvenating
the animals’ running capacity. Our study elucidates
that TRPVs relay the FBP-free status of aldolase to
the reconfiguration of v-ATPase, leading to AMPK
activation in low glucose.
INTRODUCTION
AMP-activated protein kinase (AMPK) is a pivotal sensor for moni-
toring cellular energy state and nutrient supply (Carling et al.,
2012; Herzig and Shaw, 2018; Lin and Hardie, 2018; Steinberg
and Kemp, 2009). It occurs universally as heterotrimeric com-
plexes containing catalytic a subunits and regulatory b, and g
subunits, with the g subunit providing the binding sites for the
regulatory adenine nucleotides, AMP, ADP, and ATP. When
cells encounter metabolic stress, an increase of AMP:ATP and
ADP:ATP ratios occurs. Binding of AMP to AMPK causes
allosteric activation. Moreover, binding of AMP or ADP, also en-
hances phosphorylation of Thr172 on the a-subunit by therotein kinase (AMPK), which responds to decreased nutrient
energy levels. Researchers at Xiamen University in China
response to glucose deprivation and link calcium signaling,
potential channels (TRPV) to AMPK responses. This pathway
ic capacitor to provide graded energy responses. Given that
eased AMPK, the investigators were able to pharmacologi-
has previously proved quite challenging, and show that the
thor(s). Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
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Figure 1. TRPV1–4 Interact with FBP-Unoccupied Aldolase and Are Physically Required for Lysosomal AMPK Activation in Low Glucose
(A) FBP at physiologically relevant concentrations abolishes the interaction between endogenous TRPV4 and aldolase. Light organelles were prepared from 2-h
glucose-starved MEFs and aliquoted, followed by addition of FBP at concentrations indicated. Aldolases (represented by ALDOA) were immunoprecipitated,
followed by immunoblotting using the indicated antibodies. Note that the polyclonal antibody raised in rabbit by His-tagged ALDOAwas able to react with all three
isozymes of aldolase, as validated in Figure S1G. The antibody against endogenous TRPV4 was validated in Figure S1B.
(B) TRPV channels are functionally redundant in mediating AMPK activation under glucose starvation. TRPV1⁄, TRPV2⁄, TRPV3⁄, TRPV4⁄, TRPV-QKO
MEFs, and wild-type (WT) MEFs as control, were incubated in DMEMwith or without 25-mM glucose for 2 h, followed by analysis of p-AMPKa and p-ACC. AMPK
activation was virtually abolished in TRPV-QKO MEFs in which no TRPV was detectable by the antibodies.
(C) FBP dampens the association between endogenous TRPVs and aldolase. Lysates prepared from 2-h glucose-starved MEFs were mixed with 10 mM FBP.
Aldolase was immunoprecipitated, followed by immunoblotting using the indicated antibodies. The antibody against endogenous TRPV1 was validated in
Figure S2B (left panel).
(legend continued on next page)
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upstream kinase liver kinase B1 (LKB1), and inhibits Thr172
dephosphorylation by protein phosphatases; all three effects are
opposed by binding of ATP (Ross et al., 2016). Thr172 can
also be phosphorylated by the alternative upstream kinase
Ca2+/calmodulin-dependent protein kinase kinase-2 (CaMKK2/
CaMKKb) in response to increases in cytosolicCa2+ concentration
(Hawley et al., 2005; Hurley et al., 2005; Woods et al., 2005). Once
activated, AMPKphosphorylates awide range of downstream tar-
gets to maintain energy homeostasis, switching on catabolic
pathways that generate ATP while switching off ATP-consuming
processes (Herzig and Shaw, 2018). We have recently shown
that glucose deprivation activates AMPK in an AMP/ADP-inde-
pendent manner through a mechanism involving the scaffold pro-
tein axis inhibitor protein (AXIN) (Zhang et al., 2017). AXIN binds
LKB1 constitutively, but glucose deprivation promotes formation
of a ternary complex that includes the downstream kinase
AMPK (Zhang et al., 2013). This occurs on the surface of the lyso-
some and requires both the vacuolar H+-ATPase (v-ATPase,
which acidifies the lumenof lysosomes) and the pentamericRagu-
lator complex containing LAMTOR1-LAMTOR5 (Zhang et al.,
2014). The v-ATPase-Ragulator complex is also required in a
reciprocal manner for activation of mTORC1 when nutrient levels
are high, thus exerting a reversible switch between catabolism
and anabolism (Zhang et al., 2014). Upon glucose deprivation, a
proportion of aldolase becomes unoccupied by fructose-1,6-bi-
sphosphate (FBP) and acts as a sensor of glucose availability to
promote docking of AXIN:LKB1 to the v-ATPase:Ragulator com-
plex, which in turn leads to the formation of a ‘‘super-complex’’
comprised of the v-ATPase, Ragulator, AXIN, LKB1, and AMPK
on the lysosomal surface, referred to below as the AXIN-based
complex, and thereby allows LKB1 to phosphorylate and activate
AMPK (Zhang et al., 2017; Zhang et al., 2014; Zhang et al., 2013).
Importantly, inhibition of v-ATPase upon glucose starvation is a
prerequisite step in triggering the lysosomal pathway because
concanamycin A (ConA), a v-ATPase inhibitor (Drose and Alten-
dorf, 1997), is able to directly promote the formation of the
AXIN-based complex even under normal glucose conditions(D) TRPVs are required for inactivation of lysosomal v-ATPase in response to gl
DND-189 and Hoechst, and were then cultured in DMEMwith 25-mM glucose (no
of LysoSensor (normalized to the intensity of Hoechst) were then analyzed. Result
same below. p value was determined by Student’s t test. Representative images
(E) TRPVs are required for the lysosomal translocation of AXIN. MEFs were gluco
staining. Endogenous AXIN (green, validated previously, (Zhang et al., 2014)) an
antibody, respectively, and were imaged by confocal microscopy. ‘‘N’’ indicates
(F) TRPV proteins are required for the formation of Ragulator:AXIN:LKB1:AMPK
25-mM glucose) or glucose-starved TRPV-QKO MEFs was immunoprecipitated,
(G) TRPVs are required for the activation of AMPK in physiologically low glucose. T
for 2 h, followed by analysis of p-AMPKa and p-ACC.
(H) TRPV channels are specifically involved in the AMPK activation induced by gluc
for glucose (GS) or treated with 1 mM oligomycin, 50-mM dinitrophenol (DTP), 500
p-AMPKa and p-ACC.
(I and J) TRPVs are required for starvation-induced AMPK activation in mouse live
AAV-carried siRNAs against TRPV2, TRPV3, and TRPV4. After 4 weeks of injec
hepatocytes incubated in medium containing 3-mM glucose (resembling the c
Figure S2J) for 12 h (J) were analyzed.
(K) Requirement of TRPVs for glucose restriction-induced AMPK activation is con
ocr-2), along with its wild-type control (N2), were cultured on normal NGM agar o
worms were then lyzed, and the levels of p-AMPKa and p-ACC were determined
Experiments in this figure were performed at three times, except for (I), (J), and (
See also Figures S1 and S2.
510 Cell Metabolism 30, 508–524, September 3, 2019(Zhang et al., 2014). However, it remained unclear how the FBP-
unoccupied aldolase leads to inhibition of v-ATPase that allows
for the formation of the AXIN-based complex.
RESULTS
TRPV1–4 InteractwithFBP-UnoccupiedAldolaseandAre
Required for Lysosomal AMPKActivation in LowGlucose
To search for factors that might transmit sensing of the absence
of FBP by aldolase to the conformational changes of v-ATPase,
we performed mass spectrometry of protein complexes co-
immunoprecipitated with ALDOA from light organelle fractions
containing lysosomes. Some 114 proteins with cutoff scores
>3.69 were obtained (Table S1), which could be divided into
four major categories, as summarized in Figure S1A. Among
them, there were multiple known interactors of aldolase,
including the v-ATPase subunits V1A, V1B2, and V1E1 (Bond
and Forgac, 2008; Lu et al., 2007; Lu et al., 2001; Lu et al.,
2004), the glycolytic enzymes GAPDH and PFK1 (Ouporov
et al., 2001; Ovádi and Srere, 2000), and components of actin
and tubulin filaments (Carr and Knull, 1993; Wang et al., 1996).
We were intrigued by one candidate, TRPV4, which belongs to
the V subfamily of transient receptor potential (TRP) channels,
which play a variety of roles in different tissues in response to
chemical and physical stimuli (Clapham, 2003; Nilius and Flock-
erzi, 2014). As with other members of this family, TRPV4 has
been shown to be localized both to the plasma membrane and
endomembrane systems, including the endoplasmic reticulum
(ER) (Wen et al., 2017). We also confirmed that a portion of
TRPV4 is localized on ER by performing subcellular fractionation
(Figures S1B and S1C). We next carried out co-immunoprecipi-
tation assays to validate the interaction between aldolase and
TRPV4 in the presence or absence of FBP. Co-immunoprecipita-
tion was detected between TRPV4 and all the three isozymes
of aldolase (Figure S1D). Importantly, these interactions were
virtually abolished in the presence of 10 mM (and above) FBP
(Figure 1A), which is within the range of FBP concentrations inucose starvation. TRPV-QKO MEFs were pre-loaded with LysoSensor Green
rmal) or DMEMwithout glucose (GS) for 2 h. The relative fluorescent intensities
s are mean ± SEM; n value of each group is directly labeled on the bar, and the
of this experiment are shown in Figure S2D.
se starved and the localization of AXIN was determined by immunofluorescent
d LAMP2 (red) were stained with goat anti-AXIN antibody and rat anti-LAMP2
nucleus.
complex. Endogenous LAMTOR1 in regularly cultured (in DMEM containing
followed by immunoblotting.
RPV-QKOMEFs were incubated in DMEMcontaining 1, 3, 5, or 10mMglucose
ose starvation. TRPV-QKOMEFs, along with its wildtype control, were starved
mM sorbitol, 1 mM H2O2 or 200 mM A769662, for 2 h, followed by analysis of
r and primary hepatocytes. TRPV1⁄ mice were injected with a combination of
tion, p-AMPKa and p-ACC levels in livers from 16-h starved mice (I) and in
oncentration of plasma glucose detected in 16-h starved mice, as shown in
served in nematodes. Worms (3 days old) of the strain lacking TRPVs (osm-9;
r NGM agar containing 5 mM 2-DG for 20 h (fed with live OP50 bacteria). The
by immunoblotting.
K) twice.
Figure 2. Glucose Starvation Blocks Ca2+ Channel Activity of TRPVs
(A) Glucose starvation inhibits the activity of TRPV4 channel. A schematic diagram of the Ca2+ sensor TRPV4-GCaMP6s is shown on the top, and validation
of the sensor is shown in Figures S3A and S3B. MEFs stably expressing TRPV4-GCaMP6s were treated with glucose-free DMEM, then 5 mM A23187 (at 600 s).
The fluorescent images of TRPV4-GCaMP6s were taken at a regular interval in MEFs after 2-min incubation with the fresh medium at 37C, and the
activities of TRPV4, expressed as the change of fluorescence intensity of GCaMP6s relative to the resting fluorescence intensity (Df/f0) were plotted. The
changes in fluorescence intensities of the indicator (Df) were calculated by subtracting the resting fluorescence intensity of the indicator (f0) from each value of
absolute fluorescent intensity of the indicator (f). Data shown are selected traces from the 6 cells from 5 dishes/experiments (lower panel). Statistical results were
shown as mean ± SEM; p value by ANOVA.
(B) Summary of the features of TRPV agonists and antagonists. Individual agonists and antagonists (antag.) along with their cognate TRPV isoforms are tabulated.
(C) TRPV agonists restore the acidification of lysosomes under glucose starvation. MEFs preloaded with LysoSensor Green DND-189 and Hoechst were glucose
starved for 2 h, followed by addition of 50 nM GSK101, 100 nM capsaicin, or 0.7 mM RN for another 15 min. The relative fluorescent intensities of LysoSensor
(legend continued on next page)
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cells cultured with normal glucose (Zhang et al., 2017). These re-
sults demonstrated that aldolase interacts with TRPV4 only in the
absence of FBP.
We next tested whether TRPV4 is involved in regulating
the lysosomal AMPK activation pathway. However, unlike
LAMTOR1 deficiency, which leads to a defect of AXIN/LKB1
docking onto the lysosome for AMPK activation (Zhang et al.,
2014), knockout of TRPV4 in MEFs only partially blocked the
activation of AMPK in low glucose, as determined by the phos-
phorylation of Thr172 on AMPKa and of the primary site on the
AMPK downstream target, ACC (Figure 1B), a key marker for
determining AMPK activity in intact cells (Gowans et al., 2013).
The mammalian TRPV subfamily contains five other structurally
conserved members (Nilius and Flockerzi, 2014), suggesting
that other family members might be involved in AMPK activation.
MEFs expressed mRNAs encoding TRPV1–4, with that for
TRPV4 being the most abundant, while TRPV5 and TRPV6
mRNAs were not detected (Figure S1E); however, only TRPV1
and TRPV4, and not TRPV2 or TRPV3, were detectable by west-
ern blotting. Validation of the TRPV1 and TRPV4 antibodies,
using lysates from TRPV1⁄ or TRPV4⁄ MEFs, are shown in
Figures S1B and S2B. We next tested interactions between
TRPV1 or TRPV4 and aldolase, using either ectopically ex-
pressed or endogenous proteins. TRPV1–3, like TRPV4, all
showed interactions with aldolase in the absence of FBP (Figures
1C, S1F, and S1H–S1J; antibody against endogenous aldolase
was validated in Figure S1G), and similar to that of TRPV4, single
knockout of TRPV1, TRPV2, or TRPV3 only mildly impaired the
activation of AMPK upon glucose starvation (Figure 1B). We
therefore carried out a quadruple knockout of TRPV1–4 in
MEFs (TRPV-QKO, Figures S2A and S2B), and found that this
markedly impaired the effects of glucose starvation on the inhi-
bition of v-ATPase, lysosomal translocation of AXIN, formation
of the AXIN-based complex, and AMPK activation (Figures 1B,
1D, 1F, S2C, and S2D). Importantly, the requirement of TRPVs
covered the entire physiological range of glucose (5 mM and
below) for AMPK activation in vivo (Figure 1G) (Zhang et al.,
2017). Re-introduction of a single TRPV channel by stable
expression in TRPV-QKO MEFs restored AMPK activation
upon glucose starvation (Figure S2E, and mRNA levels of four
re-introduced TRPVs were validated in Figure S2F). These re-
sults confirmed that TRPV1–4 are functionally redundant in
glucose sensing inMEFs. They appear to be specifically involved
in AMPK activation induced by glucose starvation, because
treating TRPV-QKO MEFs with oligomycin or dinitrophenol (in-
hibiting oxidative metabolism), sorbitol (generating osmotic
stress), hydrogen peroxide (generating oxidative stress), or(normalized to the intensity of Hoechst) were then analyzed. Results aremean ± SE
in Figure S3F.
(D) TRPV agonists block glucose starvation-induced AMPK activation. MEFs wer
TRPV agonists as in (C), and analyzed by immunoblotting using the indicated an
(E) AMG-9810, an antagonist of TRPV1–4, inhibits acidification of lysosomes in n
5 mM AMG-9810 for 30 min, and the pH of lysosome was analyzed as in (C). The
(F) AMG-9810 activates AMPK in a TRPV-dependent manner. Regularly culture
p-AMPKa and p-ACC.
(G) AMG-9810 triggers lysosomal translocation of AXIN in normal glucose. Regula
translocation of AXIN was determined by immunofluorescent staining as describ
Experiments in this figure were performed three times.
See also Figures S3 and S4.
512 Cell Metabolism 30, 508–524, September 3, 2019A769662 (direct binding to AMPK) (Langendorf and Kemp,
2015; Xiao et al., 2013), all still led to robust AMPK activation
(Figure 1H). The importance of TRPV1–4 in AMPK activation
was further supported by genetic evidence that starvation-
induced AMPK activation was severely impaired in mouse liver
or primary hepatocytes from TRPV1⁄ mice with knockdown
of TRPV2–4 (Figures 1I, 1J, S2H, and S2I, note that in mouse
liver, TRPV5 and TRPV6 were not expressed, as validated in
Figure S2G) with the plasma glucose levels unchanged
compared with wild-type littermates (Figure S2J). Importantly,
in Caenorhabditis elegans mutants lacking both osm-9 and
ocr-2, the mammalian TRPV orthologs (Colbert et al., 1997;
Tobin et al., 2002; Zhang et al., 2004), glucose restriction failed
to activate AMPK (Figures 1K). Thus, TRPV members represent
newly identified factors that play essential roles in glucose-
sensing and AMPK activation via the lysosomal pathway in an
evolutionarily conserved manner.
Glucose Starvation Blocks the Ca2+ Channel Activity
of TRPVs
We next tested whether the channel activity of TRPVs is affected
by glucose starvation. We engineered a Ca2+ indicator by fusing
GCaMP6s (Chen et al., 2013) to the cytoplasmic tail of TRPV4.
The channel activity was directly monitored by the green fluores-
cence elicited by the indicator upon binding Ca2+ (the proper
subcellular localization of the indicator was validated in Fig-
ure S3A; and the intact function of the fused indicator in sensing
calcium was validated in Figures S3B and S3C). Indeed, the
TRPV4-GCaMP6s fluorescent signal was strongly inhibited
within 10 min of glucose starvation (Figure 2A) without any alter-
ation of the cytosolic pH (Figure S3D), by which time AMPK is
fully activated (Zhang et al., 2017).
Many agonists for TRPV channels have been identified,
including capsaicin (Caterina et al., 1997) for TRPV1, carvacrol
(Xu et al., 2006) for TRPV3, and GSK101 (Thorneloe et al.,
2008) and RN1747 (Vincent et al., 2009) for TRPV4 (Figure 2B).
Consistently, capsaicin, carvacrol, RN1747, or GSK101 led to
robust increases in fluorescence of the Ca2+-sensitive dye,
Fura-2, in glucose-starved MEFs (Figure S3E). The three ago-
nists also increased the acidity in lysosomes in glucose-starved
MEFs, as evidenced by the increased signal of the LysoSensor
Green DND-189 dye (Figures 2C and S3F) whose signal in-
creases when lysosomal pH is lowered (Cousin and Nicholls,
1997), indicating that they restored the activity of the v-ATPase
in glucose-starved cells. Consistently, these agonists blocked
the lysosomal translocation of AXIN and AMPK activation upon
glucose starvation (Figures 2D, S3G, and S3H). Similar effectsM; p value by ANOVA. The representative images of this experiment are shown
e incubated in DMEM with or without 25-mM glucose for 2 h, then treated with
tibodies.
ormal glucose. Regularly cultured WT and TRPV-QKO MEFs were treated with
representative images were shown in Figure S4C.
d WT and TRPV-QKO MEFs were treated as in (E), followed by analysis of
rly culturedWT and TRPV-QKOMEFs were treated as in (E), and the lysosomal
ed in Figure 1E.
B
E
G
A C
H
D
F
Figure 3. TRPVs Maintain a Local Ca2+ in Normal Glucose
(A) Ca2+ releasing-defective TRPV4 mimics glucose starvation causing constitutive AMPK activation. TRPV-QKO MEFs expressing channel activity-defective
HA-tagged TRPV4-D672A, TRPV4-D682A, or WT TRPV4 as a control, were incubated in DMEMwith or without glucose for 2 h, followed by analysis of p-AMPKa
and p-ACC.
(B, C, and E) Depletion of Ca2+ by BAPTA-AM, cell-permeable form of the local Ca2+ chelator BAPTA, triggers the lysosomal AMPK pathway. Regularly cultured
MEFswere treatedwith 100 mMBAPTA-AM for 30min, followed by analysis of lysosomal pH (B; results are shown asmean ± SEM; p value by Student’s t test), the
complex formation of Ragulator:AXIN:LKB1:AMPK (C), and the lysosomal translocation of AXIN (E).
(legend continued on next page)
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were observed using 2-APB (TRPV1–3 agonist [Hu et al., 2004])
in TRPV1/3/4 triple KO (TKO) MEFs in which only TRPV2 was
expressed (Figures S3I and S3J). No change in AMP:ATP and
ADP:ATP ratios was observed in glucose-starved MEFs
following treatment with these agonists, unlike phenformin (Fig-
ure S3K). These results further confirmed that TRPV1–4 although
expressed at different levels, can function redundantly upstream
of the v-ATPase in MEFs (Figures 1B, S1E, and S2E). These re-
sults demonstrate that it is the v-ATPase activity that is regulated
by TRPVs, and which in turn regulates AMPK activation.
We also used TRPV antagonists to test whether blocking the
channels would mimic glucose starvation. AMG-9810 is an
antagonist originally designed to inhibit TRPV1 (Gavva et al.,
2005), but several studies have found that it also inhibits other
TRPV family members such as TRPV4 (Ye et al., 2012). Indeed,
AMG-9810 dampened the Fura-2 signal in TRPV1⁄ MEFs (Fig-
ure S4A). AMG-9810 also dampened the Fura-2 signal in TRPV-
QKO MEFs rescued by expression of TRPV2, TRPV3, or TRPV4
(Figure S4B). We found that AMG-9810 directly triggered lyso-
somal complex formation and AMPK activation in MEFs cultured
in normal glucose, but not in TRPV-QKO MEFs (Figures 2E, 2F,
2G, S4C, and S4D). As an additional control, no further decrease
in TRPV4-GCaMP6s signal was detected in MEFs pre-treated
with AMG-9810 (Figure S4E). Importantly, knockout of LKB1,
but notCaMKK2, abolished AMPK activation by AMG-9810 (Fig-
ures S4F and S4G). We also confirmed that there is no change in
AMP:ATP and ADP:ATP ratios in MEFs treated with AMG-9810
(Figure S4H). Thus, TRPVs, at least 1–4, in their closed state
triggers the lysosomal AMPK activation pathway upstream of
the v-ATPase:Ragulator complex.
TRPVs Maintain a Compartmentalized Ca2+
Concentration at ER-Lysosome Contact Sites
in Normal Glucose
As TRPVs are cation channels, we addressed whether Ca2+
released by TRPVs exert effects on the lysosomal AMPK
pathway. Since TRPV1–4 redundantly regulate AMPK, we chose
TRPV4 as a representative example. Re-introduction into TRPV-
QKO MEFs of D672A or D682A mutants of TRPV4, which are
defective (also confirmed as in Figures S5A and S5B) in channel
function (Owsianik et al., 2006; Voets et al., 2002), led to consti-
tutive AMPK activation (Figure 3A). Addition of BAPTA-AM, a
cell-permeable calcium chelator (Tsien, 1980), was also suffi-
cient to trigger AMPK activation through the lysosomal pathway
both in vivo and in vitro (Figures 3B–3E and S5C). BAPTA-AM
also blocked the effects of channel agonists on the lysosomal
translocation of AXIN (Figure 3F). The calcium chelator EGTA-
AM, which binds Ca2+ more slowly than BAPTA-AM (Stern,
1992; Tsien, 1980), did not trigger the lysosomal pathway (Fig-(D) BAPTA blocks FBP from dissociating AXIN-LKB1 from LAMTOR1 on light or
bated with 10 mM FBP in the presence or absence of 500 mM BAPTA. Endogeno
(F) BAPTA-AM blocks TRPV agonists-prevented lysosomal dissociation of AXIN.
together with TRPV agonists.
(G) EGTA-AM (cell-permeable EGTA) that is unable to chelate local Ca2+, cann
EGTA-AM for 30 min, and the pH of lysosome was analyzed. Results are mean ±
(H) EGTA-AM fails to trigger the lysosomal translocation of AXIN. Regularly culture
AXIN was determined by immunofluorescent staining.
Experiments were performed three times, except (A) twice.
See also Figure S5.
514 Cell Metabolism 30, 508–524, September 3, 2019ure 3H), suggesting that Ca2+ release from TRPVs that sup-
presses AMPK activation in normal glucose was local and
transient. This agrees with results that glucose starvation did
not cause changes in bulk Ca2+ concentrations, as recorded
by cytosol-localized Fluo-3 (Figure 4A).
We then used imaging techniques to determine if TRPV4 has
co-localization with the lysosomal marker LAMP2. We indeed
observed juxtaposition of TRPV4 with LAMP2, as revealed by
immunofluorescent staining using confocal microscopy (Fig-
ure S5D). Imaging by structured illumination microscopy (SIM)
also showed that 17.17% ± 5.7% of TRPV4 puncta (2,337 of
14,160, counted in 11 cells) were juxtaposed with LAMP2 (Fig-
ure S5F, validated in Figure S5E). We also performed Stochastic
Optical Reconstruction Microscopy (STORM) to study the orga-
nization of TRPV4-lysosomal foci in vivo at the nanometer scale,
and the results clearly showed that a portion of TRPV4 is located
in apposition to LAMP2 (Figure 4B). To confirm the Ca2+ levels in
the immediate vicinity of lysosomes, GCaMP6s was fused to
the cytosol-facing C terminus of the lysosomal marker LAMP2
(LAMP2-GCaMP6s, Figure 4C, validated in Figure S5G). We
found that glucose starvation strongly blunted the fluorescent
signal, in line with the majority of LAMP2 puncta (1,621 of
1,935 or 87.44% ± 5.6%, counted in 11 cells from SIM images)
being juxtaposed with TRPV4. These findings are also consistent
with the reported observation that over 95% of lysosomes are in
apposition to ER via ER-lysosome contact sites (Rowland et al.,
2014). It is therefore reasonable to suggest that the Ca2+ ions
released by TRPV4 comes from the ER Ca2+ pool. Indeed, no
changes in TRPV4-GCaMP6s signals were detected in MEFs
treated with thapsigargin, a drug that depletes ER calcium stores
(Figures 4D, left panel, and S5H). In comparison, depletion of
extracellular Ca2+ had no effect on TRPV4-GCaMP6s intensity
during glucose starvation or under TRPV4-specific agonist
GSK101 stimulation (Figures 4D, right panel, and S5I). As an
additional control, GSK101 could still increase signals of Fura-
2 in MEFs with extracellular Ca2+ depleted, while knockout of
TRPV4 rendered GSK101 ineffective (Figure S5J). Moreover,
GSK101 failed to inhibit glucose-starvation-induced AMPK acti-
vation after the ER pool of Ca2+ had been depleted by thapsigar-
gin (Figure 4E).
It is well established that increases in bulk cytosolic Ca2+ acti-
vate AMPK via CaMKK2, unlike the localized pool of Ca2+
released from TRPV channels, which inhibits AMPK activation in
normal glucose. We previously showed that the Ca2+ ionophore
A23187 readily activates AMPK in AXIN⁄ and LAMTOR1⁄
MEFs via CaMKK2 (Zhang et al., 2014), distinct from the
lysosomal pathway that requires AXIN and LAMTOR1 and is
independent of CaMKK2 (Zhang et al., 2017). Similarly, TRPV
agonists failed to evoke CaMKK2 signaling, as monitored byganelles. Light organelles purified from 2-h-glucose-starved MEFs were incu-
us LAMTOR1 was then immunoprecipitated, followed by immunoblotting.
MEFs were treated as in Figure 2C, except that 100 mMBAPTA-AM was added
ot affect lysosomal pH. Regularly cultured MEFs were treated with 100 mM
SEM; p value by Student’s t test.
d MEFs were treated with 100 mMEGTA-AM for 30 min, and the localization of
Figure 4. TRPV Releases Ca2+ Locally from ER to the Space Formed by the Contact between ER and Lysosome
(A) Glucose starvation does not lead to significant change of global Ca2+. MEFs were preloaded with Fluo-3-AM and starved for glucose (upper graph, 5 cells),
with 100 mM BAPTA-AM added as a control (lower graph, 6 cells). Statistical results were graphed as mean ± SEM; p value by Student’s t test.
(B) STORM images of TRPV4 and LAMP2 in MEFs showing that the two markers are apposed. HA-TRPV4 (green) and Myc-LAMP2 (red) expressed in TRPV4⁄
MEFs (both expressed at close-to-endogenous levels driven by pBOBI vector) were stained with rabbit anti-HA antibody and mouse anti-Myc antibody,
respectively. The boxed areas are enlarged on the right side. The proper localization of HA-tagged TRPV4 was validated in Figure S5E.
(C) Glucose starvation leads to a decrease of Ca2+ concentration in the vicinity of lysosomes. MEFs were starved for glucose, and then treated with 5 mMA23187
(at 600 s). Data shown are selected traces from the 5 cells from 2 dishes/experiments. Statistical results were graphed as mean ± SEM; p value by ANOVA.
(D) TRPV4-released Ca2+ originates from the ER pool. MEFs were treated with 4 mM thapsigargin for 15min to deplete the ER Ca2+ pool, or incubated in Ca2+-free
DMEMcontaining 5mMEGTA to remove extracellular Ca2+ for 30min, followed by determination of the fluorescent signal of the indicator TRPV4-GCaMP6s. Data
shown are selected traces from the 3 cells from 2 dishes/experiments, and were graphed as mean ± SEM; p value by Student’s t test.
(legend continued on next page)
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phosphorylation of CaMKI, another substrate of CaMKK2 (Fig-
ure 4G). In addition, in glucose-starvedCaMKK2⁄MEFs, activa-
tion of AMPKwas fully suppressedby the TRPV4 agonist GSK101
(Figure 4F), and AMG-9810 still activated AMPK in CaMKK2⁄
MEFs (Figure S4G). Furthermore, while EGTA-AM could not
ablate the suppression of glucose starvation-induced AMPK acti-
vation by the agonist GSK101, it suppressed CaMKK2-depen-
dent AMPK activation by ionomycin (Figures S5K–S5N).
Finally, we attempted to reconstitute v-ATPase regulation by
re-introducing TRPV4 and Ca2+ to purified lysosomes. Addition
of TRPV4 alone inhibited the v-ATPase activity, co-addition of
Ca2+ relieved the inhibitory effect (Figures 4H and 4I), recapitu-
lating that local Ca2+ is required to maintain v-ATPase activity.
Aldolase Inhibits Ca2+ Channel Activity of TRPV4 in Low
Glucose or FBP
We next determined how low glucose inhibits TRPV channels via
aldolase. TRPV4 was tested as a representative. Knockdown
of aldolases blocked the effects of glucose starvation in damp-
ening the fluorescent signal obtained with TRPV4-GCaMP6s
and LAMP2-GCaMP6s (Figure 5A compare with Figures 2A
and S6A), indicating that aldolase is required to block the
TRPV4. Importantly, ectopic expression of ALDOA-D34S, which
binds FBP constitutively, failed to dampen the signal of TRPV4-
GCaMP6s and LAMP2-GCaMP6s (Figures 5B, 5C and S6B),
indicating that FBP-occupied aldolase is unable to trigger
closure of TRPV4. We conclude that TRPV4 is inhibited by
aldolase when it is unoccupied by FBP, i.e., under glucose star-
vation conditions. Interestingly, signals of TRPV4-GCaMP6s, not
only those localized on ER-lysosome contact sites, but also on
other parts of the cell, were controlled by aldolase and FBP
(see Figure 5C, in which a universally decreased of TRPV4-
GCaMP6s signals could be detected). This finding indicates
that different pools of TRPV4 can be similarly inhibited by FBP-
unoccupied aldolase as aldolase is ubiquitously localized inside
cells (apart from those interact with v-ATPase). However, it is
important to note that only the portion of TRPV4 localized in
the vicinity of lysosome has the chance to modulate v-ATPase
on the lysosome. As mentioned earlier, aldolase unoccupied
by FBP shows strong interaction with TRPVs (e.g., Figures 1A,
1C, and S1F). We therefore tested whether inhibition of TRPV4
is caused by binding of aldolase. We found that the activity of
a K535A mutant of TRPV4, which was unable to bind aldolase
(identified by deletion mapping followed by alanine mutagenesis
screening, as shown in Figures 5D and S6C–S6F), was still
capable of being regulated by its agonist and antagonist, as(E) TRPV4 agonist GSK101 cannot inhibit glucose starvation-induced AMPK activ
followed by addition of 50 nM GSK101 for another 15 min. Cells were then lyzed
(F) GSK101 inhibits glucose starvation-induced AMPK activation in CaMKK2/M
of 50 nM GSK101 for another 15 min, and p-AMPKa, and p-ACC were analyzed
(G) TRPV agonists are unable to evoke CaMKK2 signaling. 2-h glucose-starved M
carvacrol, 200 mM 2-APB, or 1 mM ionomycin for 15 min and then lyzed. The a
phorylation of CaMKI.
(H and I) Activity of v-ATPase in glucose-starved lysosomes can be restored by low
were incubated with 0.5 mM CaCl2 and 1 mg of FLAG-TRPV4 (expressed and pu
activity of v-ATPase was determined by its rate to hydrolyze ATP (I) and to transpo
are graphed as mean ± SEM; n = 3 for each condition, p value by Student’s t tes
Experiments in this figure were performed three times except those in (F) and (G
See also Figure S5.
516 Cell Metabolism 30, 508–524, September 3, 2019determined by a TRPV4-GCaMP6s-K535A indicator (Figures
5E and S6G), while AMPK activation was reduced in QKO
MEFs in which this mutant was re-expressed (Figure 5F).
Similarly, truncated ALDOA (residues 1–345, i.e., lacking the
C-terminal 19 amino acids), which was defective in binding to
TRPV1 to TRPV4, failed to rescue the AMPK activation when
re-introduced into ALDO-TKD MEFs (Figures 5G, S6H, and
S6I). These results reinforced the importance of the aldolase-
TRPV interaction in blocking channel activity and causing
AMPK activation.
Inactivated TRPV4 Protein after Ca2+ Depletion
Physically Reconfigures the Association of Aldolase
with v-ATPase
We next analyzed how the interplay between aldolase and TRPV
affects the v-ATPase and AMPK activation. It is well established
that aldolase directly interacts with various subunits of the
v-ATPase, and is required for its activity (Lu et al., 2007;
Lu et al., 2004). Indeed, knockdown of aldolase directly activates
AMPK in both WT and TRPV-QKO MEFs (Figure 6A). It thus ap-
pears that aldolase unoccupied by FBP is somehow dissociated
from the v-ATPase, driving the v-ATPase to undergo changes
that lead to AMPK activation instead. However, whenwe re-intro-
duced the K230Amutant of aldolase,which cannot form the initial
Schiff base with the substrate FBP and thus causes constitutive
AMPK activation (Morris and Tolan, 1993; Zhang et al., 2017),
AMPK was not activated in the TRPV-QKO MEFs (Figure 6B).
Therefore, the absence of FBP from aldolase is not sufficient to
cause AMPK activation, but it also requires the physical presence
of inactivated TRPVs, such as TRPV4, for re-configuring the
aldolase-v-ATPase interaction, eliciting the ultimate conforma-
tional change of v-ATPase for AMPK activation. Indeed, we found
that TRPV4 interacts with v-ATPase in glucose-starved cells (Fig-
ure 6C). Addition of both FBP and CaCl2 (mimicking the effect of
normal glucose) to lysates prepared from glucose-starved cells
strengthened the association between ALDOA and v-ATPase,
alongwithattenuationof theTRPV4:v-ATPase interaction (Figures
6C and 6D). These results imply that the association of aldolase or
TRPV4with v-ATPasemaybemutually exclusive. Consistent with
this, increased expression of TRPV4 disrupted the interaction
between ALDOA and v-ATPase, accompanied by an increase of
association between TRPV4 and the v-ATPase, but this was not
observed in normal glucose (Figure 6E). Importantly, knockout
of TRPV1–4 led to a constant interaction between ALDOA and
v-ATPase even in the absence of FBP and CaCl2 (Figure 6F).
Moreover, the truncation-mutant TRPV4-D1-144, which isation in MEFs pre-depleted of the ER pool of Ca2+. MEFs were treated as in (D),
, and p-AMPKa, and p-ACC analyzed.
EFs. Cells were incubated in glucose-free medium for 2 h, followed by addition
.
EFs were treated with 50 nM GSK101, 100 nM capsaicin, 0.7 mM RN, 100 mM
ctivity of CaMKK2 was determined by western blotting analysis of the phos-
concentration of Ca2+ in vitro. Lysosomes purified from glucose-starvedMEFs
rified in HEK293T cells, followed by elution with FLAG epitope peptide). The
rt protons (H). Results were normalized to the group without CaCl2 added, and
t.
) twice.
Figure 5. Aldolase Binds to TRPV and Inhibits its Ca2+ Channel Activity in Low FBP
(A) Aldolases are required for inhibition of TRPV channels. ALDO-TKD MEFs expressing TRPV4-GCaMP6s were incubated in glucose-free DMEM at 37C. After
2 min in the live-cell incubation chamber, the images were captured by confocal microscopy at a regular interval. After 250 s of starvation, 5 mM AMG-9810 was
added to the medium. The changes of TRPV4 activities were analyzed as described in Figure 2A. n = 3 cells from 2 dishes/experiment, and were graphed as
mean ± SEM; p value by Student’s t test.
(B and C) The FBP-constantly bound aldolase mutant ALDO-D34S fails to block the activity of TRPV4 in low glucose. MEFs (B) and HEK293T cells (C) expressing
TRPV4-GCaMP6s were incubated in glucose-free DMEM at 37C. After 2 min of incubation in the live-cell incubation chamber, the images were captured by
confocal microscopy at a regular interval. For MEFs, after 350 s of starvation, 5 mM AMG-9810 was added to the medium, and the relative fluorescent intensities
were analyzed and graphed (n = 3 cells from 3 dishes/experiment) in (B). For HEK293T cells expressingHA-ALDOA or its D34Smutant (red, labeled as #1 and #2 in
C), representative images at t = 0 s and t = 1313 s (for ALDOA) or 1440 s (for ALDOA-D34S) were shown (upper panel) and the relative fluorescent intensities
of GCaMP6s (green) were analyzed and graphed (lower panel, n = 5 cells from 2 dishes/experiment for ALDOA, and n = 7 cells from 3 dishes/experiment for
ALDOA-D34S) in (C). Statistical analysis results were shown in mean ± SEM; p value by Student’s t test.
(D) Schematic illustration of TRPV4 membrane topology. The K535 residue (in red) of TRPV4 forming the interface for aldolase, and the N-terminal region of aa
1–144 (blue) for binding to v-ATPase (as characterized below) are illustrated.
(E) Glucose starvation fails to inhibit the channel activity of TRPV4-K535A that is defective in binding to aldolase. Cells were treated and the activity of TRPV4 was
analyzed as in B, except that TRPV4-GCaMP6s-K535A was expressed in TRPV-QKO MEFs (n = 3 cells from 2 dishes/experiment). Statistical analysis data of
E were shown as mean ± SEM; p value by Student’s t test.
(legend continued on next page)
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Figure 6. Ca2+ Depletion Reconfigures the
Association of Aldolase with v-ATPase
(A) Knockdown of aldolase bypasses the require-
ment of TRPV. TRPV-QKO MEFs with knockdown
of ALDOA-C were regularly cultured, followed by
analysis of the activation of AMPK.
(B) Deficiency of TRPV prevents the constitutive
activation of AMPK caused by ALDO-K230A.
TRPV-QKOMEFs expressing HA-TRPV4 or vector
as a control were infected with lentivirus ex-
pressing HA-tagged ALDOA or ALDOA-K230A.
Cells were regularly cultured, or incubated in
glucose-free DMEM for 2 h, followed by analysis of
p-AMPKa and p-ACC.
(C andD) FBP blocks interaction between aldolase
and TRPV, while CaCl2 prevents interaction
between TRPV with v-ATPase. Lysates from
glucose-starved MEFs were mixed with 0.5 mM
CaCl2 and/or 10 mM FBP. Endogenous TRPV4 (C)
and aldolase (D) were separately immunoprecipi-
tated, followed by immunoblotting.
(E) TRPV4 competes the binding of aldolase with
v-ATPase in the absence of Ca2+. HEK293T cells
were transfected with different combinations of
Myc-TRPV4 and FLAG-ALDOA. Cells were then
lyzed, and the protein extracts were mixed with
CaCl2 and FBP, immunoprecipitated with anti-
body against endogenous ATP6V1B2, and fol-
lowed by immunoblotting.
(F) Knockout of TRPV renders the interaction
of ALDOA-v-ATPase constitutive. Experiments
were performed as in (D), except that lysates
were purified from glucose-starved TRPV-QKO
MEFs.
(G) TRPV truncation-mutant defective in binding
to v-ATPase fails to trigger lysosomal AMPK
activation. TRPV-QKO MEFs stably expressing
HA-tagged D1-144-TRPV4 mutant (unable to bind
to v-ATPase, as determined in Figure S7A), were
regularly cultured or glucose starved for 2 h,
followed by analysis of p-AMPKa and p-ACC.
(H) The mutant D1-144-TRPV4 fails to block
v-ATPase activity. Lysosomes purified from
glucose-starved MEFs were incubated with
0.5 mM CaCl2 and 1 mg of D1–144 mutant of
TRPV4. The rate of v-ATPase to hydrolyze ATP was determined. Results were normalized to the group without CaCl2 added, and are graphed as mean ± SEM;
n = 3 for each condition, p value by Student’s t test.
(I) Two-step coIP shows the coexistence of aldolase, TRPV and v-ATPase (represented by its V1A, V1B2, v0d1, and V1D subunits) in the same complex under
glucose starvation. Complex formations between FLAG-ALDOA, Myc-TRPV4 and HA-v-ATPase in glucose-starved HEK293T cells were monitored by two-step
coIP followed by immunoblotting.
(J) FRET-imaging showing that the lysosomal membrane potential was unchanged under glucose starvation. MEFs were cultured in the DMEM containing
glucose or not. The lysosomal membrane potential was determined by the relative cFRET intensity generated from DiBAC4(3)-PE-conjugated Rhodamine pair.
n = 4 (normal) and n = 3 (glucose starved) cells from 2 dishes/experiment.
Experiments in (G) and (J) were performed twice and others three times.
See also Figure S7.defective in binding to the v-ATPase, failed tomediate AMPKacti-
vation upon glucose starvation, and did not inhibit the activity of
v-ATPase based on in vitro reconstitution experiments (Figures
6G, 6H, and S7A). These observations, together with those(F) Re-introduction of TRPV4-K535A to TRPV-QKO MEFs suppresses AMPK act
K535A were regularly cultured or glucose starved for 2 h, followed by analysis o
(G) The TRPV4-binding-defective, truncated ALDOA (aa 1–345) fails to trigger lyso
WT ALDOA as a control were regularly cultured or glucose starved for 2 h, follow
Experiments were performed for three times.
See also Figure S6.
518 Cell Metabolism 30, 508–524, September 3, 2019showing the requirementof TRPVactivity in lysosomalAMPKacti-
vation (Figure 2), point to the same conclusion, i.e. that TRPV1–4
are required both physically and functionally for lysosomal AMPK
activation in response to low glucose.ivation under glucose starvation. TRPV-QKO MEFs stably expressing TRPV4-
f p-AMPKa and p-ACC.
somal AMPK activation. ALDO-TKD MEFs stably expressing ALDOA 1–345 or
ed by analysis of p-AMPKa and p-ACC.
We next dissected the roles of FBP and Ca2+ in the interaction
between aldolase and v-ATPase by adding them singly to lysates
from starved cells. FBP decreased the interaction between AL-
DOA and TRPV4 (Figures 6C and 6D). By contrast, incubation
with CaCl2 prevented interaction between TRPV4 and v-ATPase,
restoring the interaction between ALDOA and v-ATPase (Figures
6C and 6D), consistent with Ca2+ being able to activate v-
ATPase in vitro, as shown in Figures 4H and 4I. Importantly, AL-
DOA interacts with TRPV4 as long as FBP is low, regardless of
Ca2+ concentrations (Figures 6C and 6D). This indicates
that the binding of FBP-unoccupied aldolase to TRPV4, prior
to the change in Ca2+, is the priming step that triggers the
glucose-sensing cascade. Subsequently, the reduced level of
Ca2+ enhances the interaction of TRPV4 with v-ATPase, re-
configuring the aldolase:v-ATPase complex into a ternary
aldolase:TRPV4:v-ATPase ‘‘sandwich’’. The existence of an
aldolase:TRPV4:v-ATPase complex was further confirmed by a
two-step co-immunoprecipitation assay, showing that all three
components were detected in the final immunoprecipitates
generated from glucose-starved cells (Figure 6I).
The v-ATPase is an electrogenic pump, and its activity in pro-
ton transport is maintained both by ATP hydrolysis (directly
providing energy for proton transport against an electrochemical
gradient) and flux of counterions (dissipating the electrical poten-
tial across the lysosomal membrane generated by proton accu-
mulation) (Nishi and Forgac, 2002). We thus determined whether
the lysosomal counterion flux was suppressed under glucose
starvation conditions, by directly measuring the lysosomal mem-
brane potential at different time points of glucose starvation
through an in vivo FRET-based method (Koivusalo et al., 2011).
The result showed that the lysosomal membrane potential hardly
changed under glucose starvation (Figure 6J, validated in Fig-
ure S7B). This suggests that the inhibition of v-ATPase during
glucose deprivation is not caused by restraint on proton accu-
mulation, or a defect in counterion conductance. Combining
the observation that the V1 and v0 domains of v-ATPase were
still present in purified lysosomes from cells starved of glucose
for 4 h (Figure S7C), we conclude that aldolase and the v-ATPase
are not dissociated in low glucose, as has been reported in the
yeast system (Lu et al., 2004).
Inhibition of TRPV1–4 Increases Physical Fitness in
Aged Mice
Finally, we tried to explore potential pharmacological effects of
TRPVs as regulators of AMPK. The age-related metabolic
decline and reduced fitness result in decreased exercise capac-
ity, which has been recognized as a strong predictor of morbidity
andmortality in humans (Paffenbarger et al., 1993; Sandvik et al.,
1993). Activation of AMPK is well known as a way to improve
physical fitness by promoting fatigue resistance and the mallea-
bility of muscle (Bujak et al., 2015; Narkar et al., 2008; Steinberg
and Jørgensen, 2007), and in fact has been proposed as a prom-
ising way to retard aging-associated syndromes (Burkewitz
et al., 2014). Unfortunately, AMPK in aged muscle is difficult to
be activated by exercise or even pharmacological drugs such
as AICAR (Ljubicic and Hood, 2009; Park et al., 2017; Reznick
et al., 2007).We thus tested the effects of AMG-9810, an inhibitor
to TRPV1–4 that activates AMPK, in 1.5-year-old mice. It was
found that administration of the drug activated AMPK in themice, without altering the adenylate ratios (Figures 7A and 7B).
Importantly, AMG-9810 caused much greater AMPK activation
in aged muscles compared with A-769662 and phenformin,
two classical activators of AMPK (Figure 7A). Strikingly, AMG-
9810, after two months of administration, doubled the running
capacity of the aged mice (Figure 7C). As NAD+ has been shown
to be increased by AMPK (Cantó et al., 2009), and is regarded as
a symbol of physical fitness including running capacity (Zhang
et al., 2016), we measured the levels of NAD+, and found that
AMG-9810 indeed elevated levels of NAD+ (Figure S7D). Impor-
tantly, this effect was impaired whenAMPKb2, amuscle-specific
isoform of AMPK, was knocked down (Figure 7D). Taken
together, these results indicate that inhibition of TRPV1–4 pro-
vide a way to overcome the difficulty to activate AMPK in aged
animals.
DISCUSSION
In the current study, we have unveiled a missing link in glucose
sensing, specifically between the lack of FBP-binding to
aldolase and the formation of the lysosomal AMPK-activation
complex. When glucose supply is abundant, FBP-occupied
aldolase binds to the v-ATPase and acts as an integral compo-
nent to maintain its activity. In low glucose, FBP-unoccupied
aldolase interacts with juxtaposed TRPV1–4 channels to sup-
press their channel activity. As a result, the local Ca2+ concentra-
tion decreases at the ER-lysosome contact site, which in turn
renders TRPV1–4 accessible to the v-ATPase, generating a
ternary complex between aldolase, TRPV and the v-ATPase.
The v-ATPase is thus inhibited, promoting the translocation of
the AXIN:LKB1 complex to the lysosome and leading to AMPK
activation (Figure 7E). A conceivable advantage of inserting
another step between aldolase and the v-ATPase is that TRPV
channels, along with fluctuations in their released calcium ions,
act as buffers or dampers that prevent the activity of v-ATPase
from oscillating too rapidly. Even when bound to actin filaments
that inhibit the enzyme (Hu et al., 2016), aldolase exhibits a high
rate in converting FBP to phosphotrioses, undergoes rapid cy-
cles between FBP-bound and unbound states. This might lead
to severe oscillations in v-ATPase activity if the latter was directly
controlled by the availability of FBP to aldolase. The localized
release of Ca2+, which would be retrieved by various nearby
Ca2+ transporters and pumps or be lost by diffusion into the cyto-
solic space nearby, is tightly clamped and thus remains at a rela-
tively constant level, preventing TRPV1–4 from interacting with
v-ATPase (Mulier et al., 2017; Nita et al., 2016). However, as
glucose availability drops, a greater percentage of aldolase
would become unoccupied by FBP andmore TRPV1–4 channels
would be inhibited, leading to a decrease of the local Ca2+ con-
centration. There might be a threshold below which the local
Ca2+ concentration must drop to allow the v-ATPase to interact
with TRPV1–4, thus triggering interaction of AXIN:LKB1 with the
lysosome and AMPK activation. Therefore, the involvement of
TRPV/Ca2+ may buffer oscillations in FBP, like an electric capac-
itor that filters out fluctuations when attached to an electronic
circuit, and provides a more graded regulation of v-ATPase (Fig-
ure S7E). With the involvement of TRPV1–4 channels, our work
has successfully reconstituted the effects of glucose availability
on the v-ATPase, thus resolving a long-standing question in thisCell Metabolism 30, 508–524, September 3, 2019 519
Figure 7. Models for the Roles of TRPV in
Glucose Sensing and AMPK Activation
(A) Inhibition of TRPV efficiently activates AMPK in
muscle from aged mice. Mice at 1.5-year-old were
intraperitoneally injected with vehicle (10% (w/v)
Kolliphor), 30 mg/kg of A769662, 150 mg/kg of
phenformin, or 20 mg/kg of TRPV inhibitor AMG-
9810 (all formulated in the vehicle). 1 h after injec-
tion, muscles were excised and homogenized,
followed by analysis of p-AMPKa and p-ACC levels.
(B) AMG-9810 has no effect on AMP:ATP and
ADP:ATP ratios in muscle. Mice (1.5-year-old)
were treated as in (A), and adenylate nucleotide
ratios in muscle tissues weremeasured by CE-MS.
Results are mean ± SD; p value by Student’s t test,
n = 3.
(C) Inhibition of TRPV robustly increases the
running capacity of aged mice. Mice (1.5-year-old)
were intraperitoneally injected with 20 mg/kg
AMG-9810 daily for two months. The distance (in
meters) on the treadmill before exhaustion was
graphed. Results are mean ± SEM; p value by
Student’s t test, n = 13 for vehicle group and n = 14
for AMG-9810 group.
(D) Inhibition of TRPV increases the NAD+ levels in
an AMPK-dependent manner. Mice (1.5-year-old)
were injected with AAV-carried siRNAs against
AMPKb2. After 4 weeks of injection, mice were
intraperitoneally injectedwith 20mg/kg AMG-9810
daily for another three weeks, and the muscular
NAD+ levels were measured by HPLC-MS. Results
are mean ± SEM; p value by ANOVA, n = 8 for each
group.
(E) Simplified models depicting how absence of
glucose/FBP is sensed and relayed from aldolase
to TRPVs (TRPV1–4 characterized in MEFs), to
v-ATPase, and then to the formation of the AXIN-
based lysosomal complex for AMPK activation.
When glucose (Glc) supply is abundant, the FBP-
occupied aldolase is associated with v-ATPase as
an integral component for maintaining its activity,
and the TRPV channels release Ca2+ locally to the
ER-lysosome contact site (upper left panel). In low
glucose, FBP-unoccupied aldolase interacts with
and inhibits the juxtaposed TRPV on the ER (upper
right panel). After the local Ca2+ dissipates, TRPV
becomes accessible to v-ATPase, thereby re-
configuring aldolase:v-ATPase to ‘‘sandwich-like’’
aldolase:TRPV:v-ATPase (lower left panel). Sub-
sequently, v-ATPase is inhibited, and allows AXIN/LKB1 to bind (Zhang et al., 2014), leading to the formation of the AXIN-based AMPK-activating complex for
AMPK activation by LKB1 (lower right panel).
Experiments in this figure were performed twice.
See also Figure S7.field (M. Kane, 2012). Of note, a recent study showed that com-
bined starvation of glucose and serum might even increases
acidity of newly generated lysosomes before increases of auto-
phagic fluxes (McGuire and Forgac, 2018).
Our studymay also suggest a new type of TRPV1–4 activation.
Traditionally, TRPV1–4 are known to be stimulated by physical
and chemical signals. Here, we found that the TRPV1–4 are
constitutively active, by default, so long as glucose is present
and no aldolase is in contact with the channels. It is also note-
worthy that different concentrations of TRPV agonists might
yield differing results in the context of AMPK activation. For
example, it has been reported that capsaicin results in AMPK520 Cell Metabolism 30, 508–524, September 3, 2019activation in a Ca2+- and CaMKK2-dependent manner (Kim
et al., 2013). However, the concentrations of capsaicin used in
those studies (>10 mM) were much higher than that used here
(100 nM), and may have caused a bulk, global increase in Ca2+
concentration that might also be blocked by EGTA-AM (Ching
et al., 2012; Ying et al., 2013). Thus, excessively high concentra-
tions of capsaicin may cause activation of AMPK via a mecha-
nism different from that studied here.
Another interesting issue is the reciprocal regulation of AMPK
and mTORC1, as glucose-sensing and amino acid-sensing on
the lysosome share use of the same v-ATPase:Ragulator com-
plex (Zhang et al., 2014). One unanswered question is why amino
acid starvation does not activate AMPK, while glucose starvation
activates AMPK and concomitantly inhibits mTORC1. We show
here that amino acid starvation does not affect the activity of
TRPV4 (Figure S7F). Furthermore, TRPV agonists cannot restore
lysosomal localization or activity of mTORC1 under conditions of
amino acid starvation, although they can restore v-ATPase activ-
ity and hence suppress AMPK activation in low glucose (Figures
S7G and S7H). It therefore appears that distinct accessory
factors affect the v-ATPase:Ragulator complex in different
ways. Moreover, our finding of TRPV as an upstream modulator
of AMPK may provide new avenues for identifying drugs that
treat related metabolic diseases, and improve physical fitness
in aged people.
Limitations of Study
In this study, we have shown that in MEFs, as well as in the
mouse liver, TRPV channels function redundantly upstream of
the v-ATPase and relay sensing of low glucose/FBP by aldolase
to AMPK activation. Since MEFs and mouse liver are found to
express only TRPV1–4, it therefore remains to be determined if
the remaining two members (TRPV5 and TRPV6) play the same
role as do the members 1–4 in different tissues. It is also worthy
investigating whether there are other factors augmenting the
tethering between the ER and lysosome and participating in
AMPK regulation.
Through utilizing the GCaMP6s-TRPV4 indicator and
different dyes for Ca2+ imaging in different genetic back-
grounds, we demonstrated that TRPVs could be inhibited by
the FBP-unoccupied aldolase inside cells. Limitation of current
patch clamping techniques has hindered a direct recording of
the inhibition of TRPVs by the FBP-unoccupied aldolase in
low glucose. In addition, as the concentrations of Ca2+at the
ER-lysosome contact fluctuate along with the variation of
cellular glucose levels, it is formally possible that its decrease
or increase may have accompanying roles in modulating
other proteins and hence physiological roles beyond the regu-
lation of AMPK activity.
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit polyclonal antibody against LAMTOR1 Zhang et al., 2014 N/A
Rabbit polyclonal antibody against mouse aldolase This paper N/A
Rabbit anti-phospho-AMPKa-T172 antibody Cell Signaling Technology cat. #2535; RRID: AB_331250
Rabbit anti-AMPKa antibody Cell Signaling Technology cat. #2532; RRID: AB_330331
Rabbit anti-AMPKb2 antibody Cell Signaling Technology cat. #4148; RRID: AB_560862
Rabbit anti-phospho-ACC-Ser79 antibody Cell Signaling Technology cat. #3661; RRID: AB_330337
Rabbit anti-ACC antibody Cell Signaling Technology cat. #3662; RRID: AB_2219400
Rabbit anti-LKB1 antibody Cell Signaling Technology cat. #3047; RRID: AB_2198327
Rabbit anti-AXIN1 antibody Cell Signaling Technology cat. #2074; RRID: AB_2062419
Rabbit anti-ALDOA antibody Cell Signaling Technology cat. #8060; RRID: AB_2797635
Rabbit anti-b-tubulin antibody Cell Signaling Technology cat. #2128; RRID: AB_823664
Mouse anti-Myc-tag antibody Cell Signaling Technology cat. #2276; RRID: AB_331783
Mouse anti-phospho-p70S6K-T389 antibody Cell Signaling Technology cat. #9234; RRID: AB_2269803
Mouse anti-p70S6K antibody Cell Signaling Technology cat. #9202; RRID: AB_331676
Rabbit anti-mTOR antibody Cell Signaling Technology cat. #2983; RRID: AB_2105622
Rabbit anti-T7 tag antibody Cell Signaling Technology cat. #13246; RRID: AB_2798161
Rabbit anti-HA tag antibody Cell Signaling Technology cat. #3724; RRID: AB_1549585
Rabbit anti-PDI antibody Cell Signaling Technology cat. #3501; RRID: AB_2156433
Rabbit anti-clathrin antibody Cell Signaling Technology cat. #4796; RRID: AB_10828486
Rabbit anti-N-cadherin antibody Cell Signaling Technology cat. #13116; RRID: AB_2687616
HRP-conjugated mouse anti-rabbit IgG antibody Cell Signaling Technology cat. #5127; RRID: AB_10892860
Rabbit anti-TRPV1 antibody Alomone Labs cat. ACC-030; RRID: AB_2313819
Rabbit anti-TRPV4 antibody Alomone Labs cat. ACC-034; RRID: AB_2040264
Rabbit anti-calreticulin antibody Proteintech cat. 27298–1-AP;
Rabbit anti-ATP6V1B2 antibody Abcam cat. ab73404; RRID: AB_1924799
Rabbit anti-ATP6V1B1 + ATP6V1B2 antibody Abcam cat. ab200839;
Rabbit anti-CaMKI antibody Abcam cat. ab68234; RRID: AB_1140889
Rabbit anti-phospho-CaMKI-T177 antibody Abcam cat. ab62215; RRID: AB_940775
Mouse anti-ATP6v0d1 antibody Abcam cat. ab56441; RRID: AB_940402
Rat anti-LAMP2 antibody Abcam cat. ab13524; RRID: AB_369111
Rabbit anti-ATP6v0c antibody Novus Biologicals cat. NBP1-59654; RRID: AB_11004830
Anti-flag M2 affinity gel Sigma cat. A2220; RRID: AB_10063035
Atto 488 goat anti-rabbit IgG antibody Sigma cat. 18772; RRID: AB_1137637
Goat anti-AXIN antibody Santa Cruz Biotechnology cat. sc-8567; RRID: AB_2227789
Goat anti-TRPV4 antibody Santa Cruz Biotechnology cat. sc-47527; RRID: AB_2256617
Mouse anti-HA antibody Santa Cruz Biotechnology cat. sc-7392; RRID: AB_627809
Mouse anti-goat IgG-HRP antibody Santa Cruz Biotechnology cat. sc-2354; RRID: AB_628490
HRP-conjugated goat anti-mouse IgG antibody Jackson ImmunoResearch cat. 115-035-003; RRID: AB_10015289
HRP-conjugated goat anti-rabbit IgG antibody Jackson ImmunoResearch cat. 111-035-003; RRID: AB_2313567
Alexa Fluor 405 goat anti-rabbit IgG antibody Molecular Probes cat. A31556; RRID: AB_221605
Alexa Fluor 488 donkey anti-goat IgG antibody Molecular Probes cat. A11055; RRID: AB_2534102
Alexa Fluor 488 donkey anti-mouse IgG antibody Molecular Probes cat. A21202; RRID: AB_141607
Alexa Fluor 488 donkey anti-rabbit IgG antibody Molecular Probes cat. A21206; RRID: AB_2535792
Alexa Fluor 568 donkey anti-mouse IgG antibody Molecular Probes cat. A10037; RRID: AB_2534013
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Alexa Fluor 568 donkey anti-goat IgG antibody Molecular Probes cat. A11057; RRID: AB_142581
Alexa Fluor 594 donkey anti-rat IgG antibody Molecular Probes cat. A21209; RRID: AB_2535795
Alexa Fluor 594 donkey anti-rabbit IgG antibody Molecular Probes cat. A21207; RRID: AB_141637
Alexa Fluor 594 donkey anti-goat IgG antibody Molecular Probes cat. A11058; RRID: AB_2534105
Alexa Fluor 568 goat anti-rat IgG antibody Molecular Probes cat. A11077; RRID: AB_2534121
Alexa-Fluor 647 donkey anti-mouse IgG antibody Molecular Probes cat. A31571; RRID: AB_162542
Bacterial and Virus Strains
OP50 the Caenorhabditis Genetics
Center (University of Minnesota)
N/A
BL21 Invitrogen cat. C609601
Cre Recombinase Adenovirus Vector Biolabs cat. 1045
Chemicals, Peptides, and Recombinant Proteins
HEPES Gibco cat. 21063
Polyethylenimine Polysciences cat. #23966
Glucose Sigma cat. G7021
CaCl2 Sigma cat. C5670
MnCl2 Sigma cat. 63535
phosphoenolpyruvate Sigma cat. P7002
NADH Sigma cat. N8129
pyruvate kinase Sigma cat. P9136
lactate dehydrogenase Sigma cat. SAE0049
FITC-dextran Sigma cat. FD10S
Lysosome Isolation Kit Sigma cat. LYSISO1
Endoplasmic Reticulum Isolation Kit Sigma cat. ER0100
Capsaicin Sigma cat. 360376
GSK101 Sigma cat. G0798
RN-1747 Sigma cat. R1033
Carvacrol Sigma cat. W224502
Diazoxide Sigma cat. D9035
BAPTA-AM Sigma cat. O8001
BAPTA Sigma cat. A4926
Ionomycin Sigma cat. I3909
Oligomycin A Sigma cat. 75351
2,4-dinitrophenol Sigma cat. 34334
H2O2 Sigma cat. 323381
Sorbitol Sigma cat. S6021
Phenformin Sigma cat. P7045
Octyl b-D-glucopyranoside Sigma cat. O8001
Digitonin Sigma cat. D141
Saponin Sigma cat. S7900
Triton X-100 Sigma cat. T9284
Concanamycin A Sigma cat. C9705
DTT Sigma cat. 43815
MEA Sigma cat. 30070
Glucose oxidase Sigma cat. G2133
Catalase Sigma cat. C40
Imidazole Sigma cat. I5513
IPTG Sigma cat. I6758
L-glutathione reduced Sigma cat. G6013
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RPMI 1640 Amino Acids Solution Sigma cat. R7131
Thapsigargin Sigma cat. T9033
2-DG Sigma cat. D8375
Kolliphor P188 Sigma cat. K4894
Acetic acid solution Sigma cat. 45754
Ammonium hydroxide solution Sigma cat. 338818
Formaldehyde solution Sigma cat. F8775
FLAG Peptide Sigma cat. F3290
Nickel Affinity Gel Sigma cat. P6611
GSK205 Calbiochem cat. 616522
AMG-9810 Santa Cruz Biotechnology cat. sc-201477
EGTA-AM Santa Cruz Biotechnology cat. sc-203937
FBP Santa Cruz Biotechnology cat. sc-214805
2-APB Tocris cat. 1224
A769662 Tocris cat. 3336
Fura-2-AM Molecular Probes cat. F14185
Fura-2 Molecular Probes cat. F6799
CDFA-SE Molecular Probes cat. V12883
Pluronic F-127 Molecular Probes cat. P3000MP
Fluo-3-AM Molecular Probes cat. F14218
Hoechst Molecular Probes cat. 33342
LysoSensor Green DND-189 Molecular Probes cat. L7535
SNARF-5F Molecular Probes cat. S23923
CaEGTA stock solution Molecular Probes cat. C3008MP
ProLong Diamond Antifade Mountant Molecular Probes cat. P36970
ProLong Live Antifade Reagent Molecular Probes cat. P36975
Ammonium acetate Millipore cat. 5330040050
Acetonitrile Millipore cat. 1000292500
RPMI 1640 Medium w/o amino acids US Biological cat. R8999
TRIzol Invitrogen cat. 15596
DEPC-treated water Invitrogen cat. AM9922
RQ1 RNase-free DNase Promega cat. M6101
GoTaq 1-step RT-qPCR enzyme mix Promega cat. A6020
RiboLock RNase inhibitor Thermo Fisher cat. E00381
NeutrAvidin Agarose Thermo Fisher cat. 29201
EZ-Link Sulfo-NHS-SS-Biotin Thermo Fisher cat. 21331
M-MLV reverse transcriptase Takara cat. 2641A
Doxycycline Selleckchem cat. S4163
A-769662 Selleckchem cat. S2697
Protease inhibitor cocktail Roche cat. 04693116001
Dulbecco’s modified Eagle’s medium Gibco cat. 11965
Lipofectamine 2000 Invitrogen cat. 11668-027
Glucose-free DMEM Gibco cat. 11966
DMEM without phenol red Gibco cat. 21063
MEM Amino Acids Solution Gibco cat. 11130-077
MEM Vitamin Solution Gibco cat. 11120052
Liver Perfusion Media Gibco cat. 17701
Liver Digest Buffer Gibco cat. 17703
William’s medium E Gibco cat. 32551
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Glutamax Gibco cat. 35050
Sodium pyruvate Gibco cat. 11360
Glutathione Sepharose 4 Fast Flow Gel GE Healthcare cat. 17–5132
ACC tide (HMRSSMSGLHLVRRR) GenScript N/A
Internal standards 1 Human Metabolome Technologies cat. H3304-1002
Internal standards 3 Human Metabolome Technologies cat. H3304-1104
Critical Commercial Assays
GoScript Reverse Transcription System Promega Cat. #A5001
GoTaq qPCR Master Mix Promega Cat. #A6002
Deposited Data
Mendeley Dataset (Blot quantification data) This paper https://data.mendeley.com/datasets/p3zgm58ksw/
draft?a=10c923e7-0295-4f9c-ad63-e7e811c789da
Experimental Models: Cell Lines
Human: HEK293T cells ATCC CRL3216; RRID: CVCL_0063
Human: AD293 (Adeno-X 293) cells Clontech cat. 632271
Mouse: primary hepatocytes from C57BL/6J
male mice
The Jackson Laboratory Stock No: 000664 Black. 6
Experimental Models: Organisms/Strains
Mouse: LAMTOR1F/F Zhang et al., 2014 N/A
Mouse: TRPV1-/- The Jackson Laboratory Dr. David Julius; RRID: MGI:4417977
Mouse: CaMKK2-/- The Jackson Laboratory Dr. Talal Chatila; RRID: MGI:4941485
Mouse: LKB1F/F Frederick National Laboratory
for Cancer Research
Dr. Ron DePinho; RRID: MGI:5659884
Caenorhabditis elegans: var. Bristol the Caenorhabditis Genetics
Center (University of Minnesota)
N2; RRID: WB-STRAIN:N2_(ancestral)
Caenorhabditis elegans: osm-9(ky10);
ocr-2(ak47); ocr-1(ak46)
the Caenorhabditis Genetics
Center (University of Minnesota)
FG125; RRID: WB-STRAIN:FG125
Oligonucleotides
siRNA targeting sequence: mAldoa (#1):
5’-CCAAGTGGCGCTGTGTGCT-30
Zhang et al., 2017 N/A
siRNA targeting sequence: mAldob (#1):
5’-GCTCTCTGAGCAGATCCAT-30
Zhang et al., 2017 N/A
siRNA targeting sequence: mAldoc (#1):
5’ -GAGTCTAGAGCTTATGTCT-30
Zhang et al., 2017 N/A
siRNA targeting sequence: mTrpv2:
5’-GGTGCTTCAGGGTGGAGGAAG-3’
This paper N/A
siRNA targeting sequence: mTrpv3:
5’-GGAGAACGTCTCCAAAGAAAG-3’
This paper N/A
siRNA targeting sequence: mTrpv4:
5’-GACATCCCTGCACATTGCCAT-3’
This paper N/A
siRNA targeting sequence: mAMPKb2:
5’-CTCATCTGCAATCAAATGC-3’
This paper N/A
sgRNA targeting sequence: mTrpv1:
5’-GGAGTCGCACCCGGCTTTTT-3’
http://crispr.mit.edu N/A
sgRNA targeting sequence: mTrpv1:
5’-CAGGAGCATCTTCGACGCTG-3’
http://crispr.mit.edu N/A
sgRNA targeting sequence: mTrpv2:
5’-CGGTCACGGTCAAACCGATT-3’
http://crispr.mit.edu N/A
sgRNA targeting sequence: mTrpv2:
5’-GGTACTTGCTGGTCCGGCGC-3’
http://crispr.mit.edu N/A
sgRNA targeting sequence: mTrpv3:
5’-AGTACAACAGGGTTCCCGCC-3’
http://crispr.mit.edu N/A
(Continued on next page)
e4 Cell Metabolism 30, 508–524.e1–e12, September 3, 2019
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
sgRNA targeting sequence: mTrpv3:
5’-ATCTTCGCGGCTGTGTCCGA-3’
http://crispr.mit.edu N/A
sgRNA targeting sequence: mTrpv4:
5’-TGTCGTTGCGCCCG TTGCTT-3’
http://crispr.mit.edu N/A
sgRNA targeting sequence: mTrpv4:
5’-GTAAGTGCCGTAGTCGAACA-3’
http://crispr.mit.edu N/A
Primer: 5’-CCGGCTTTTTGGGAAGGGT-3’ and
5’-GAGACAGGTAGGTCCATCCAC-3’ for mTrpv1
PrimerBank https://pga.mgh.
harvard.edu/primerbank/
N/A
Primer: 5’-GGACCCAAATCGGTTTGACC-3’ and
5’-GCGCAGGTACTCTAGCAGTC-3’ for mTrpv2
PrimerBank https://pga.mgh.
harvard.edu/primerbank/
N/A
Primer: 5’-ACGGTCACCAAGACCTCTC-3’ and
5’-GACTGTTGGGATTGGATGGGG-3’ for mTrpv3
PrimerBank https://pga.mgh.
harvard.edu/primerbank/
N/A
Primer: 5’-AAACCTGCGTATGAAGTTCCAG-3’ and
5’-CCGTAGTCGAACAAGGAATCCA -3’ for mTrpv4
PrimerBank https://pga.mgh.
harvard.edu/primerbank/
N/A
Primer: 5’-TGCTG CTATAATGCTGATGGAG-3’ and
5’- GCACGGACTAGGTTCACATTCT -3’ for mTrpv5
PrimerBank https://pga.mgh.
harvard.edu/primerbank/
N/A
Primer: 5’-GACCAGACACCTGTAAAGGAAC-3’ and
5’-AGACACAGCACATGGTAAAGC-3’ for mTrpv6
PrimerBank https://pga.mgh.
harvard.edu/primerbank/
N/A
Recombinant DNA
CMV-GCaMP6s Addgene plasmid #40753
LentiCRISPR v2 Addgene plasmid #52961
pLL3.7 vector Adegene plasmid #11795
pcDNA3.3 vector Thermo Fisher cat. K830001
pBOBI vector Miyoshi et al., 1998 N/A
pLVX-IRES vector Takara cat. 631849
AAV2 inverted terminal repeat (ITR) vectors
pseudo-typed with AAV9 capsid
Bish et al., 2008 N/A
pET-28a Novagen cat. 70777
pGEX4T-1 GE Healthcare cat. 28-9545-49
Software and Algorithms
StepOne software version 2.3 Applied Biosystems https://www.thermofisher.com
Zen 2012 Zeiss https://www.zeiss.com
DeltaVision OMX system GE Healthcare https://www.gelifesciences.com
NIS Elements software with STORM package
version 4.30 build 1053
Nikon https://www.nikon.com
Qualitative Analysis B.06.00 Agilent https://www.agilent.com
SPSS Statistics 17.0 IBM https://www.ibm.com
GraphPad Prism 6 Graphpad https://www.graphpad.com
Imaris 7.4.0 Bitplane https://www.bitplane.com
ImageJ National Institutes of Health https://imagej.nih.gov/ij/CONTACT FOR REAGENT AND RESOURCE SHARING
Requests for reagents and resources should be directed to and will be fulfilled by the Lead Contact, Sheng-Cai Lin (linsc@xmu.
edu.cn).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse Studies
Protocols for all animal experiments were approved by the Institutional Animal Care and the Animal Committee of Xiamen University.
Mice were housed with free access to water and standard diet (65% carbohydrate, 11% fat, 24% protein). The light was on from
8 a.m. to 8 p.m. Male littermate controls were used throughout the study.Cell Metabolism 30, 508–524.e1–e12, September 3, 2019 e5
CRISPR Knockout of TRPV1-4
The genes (mTrpv1, mTrpv2, mTrpv3, and mTrpv4) were deleted from MEFs using the CRISPR-Cas9 system. Nucleotides were
annealed to their complements containing the cloning tag aaac, and inserted into the back-to-back BsmBI restriction sites of lenti-
CRISPRv2 vector. The four constructs were then separately subjected to lentivirus packaging using HEK293T cells in which cells
were transfected with 2-3 mg of DNA in Lipofectamine 2000 transfection reagent per well of a 6-well plate. At 30 hr post transfection,
the four kinds of virus were collected and then added in 1:1:1:1 ratio toMEFs (cultured to 15%confluence) for another 72 hr-infection.
When cells were approaching to confluency, they were single-cell sorted into 96-well dishes. Clones were expanded and evaluated
for knockout status by sequencing.
Caenorhabditis elegans Studies
Worms were maintained on nematode growth medium (NGM) plate with OP50 as standard food (Brenner, 1974). All worms were
cultured at 20C. The osm-9(ky10); ocr-2(ak47) strain was obtained by crossing osm-9(ky10); ocr-2(ak47); ocr-1(ak46) strain
(FG125) with N2, and outcrossed 6 times to N2 prior to the experiment. Glucose restriction was performed as described previously
(Schulz et al., 2007). Plates used for the treatment of glucose restriction were prepared from the same batch of NGM agar as the
control plates.
METHOD DETAILS
Treadmill Endurance Test
The treadmill endurance test was performed as described previously (Park et al., 2017), with minor modifications. Briefly, test was
performed during dark cycle. Micewere trained on Rodent Treadmill NG (UGObasile, cat. 47300) at 10m/min for 5min for 2 days. For
the treadmill endurance test, the treadmill was set at a 15 incline, and the speed of treadmill was set to increase in a ramp-mode
(10 m/min for 10 min followed by an increase to final speed of 18 m/min within 15 min). The test was terminated when mice reached
exhaustion, which was defined as staying immobilized after 30 s of electric shocks (2 Hz, 0.5 mA).
Packaging and Injection of Adeno-associated Virus
Adeno-associated virus (AAV) was packaged in HEK293T cells following the protocol from Grieger et al. (2006). Briefly, cells used for
in-house viral production weremaintained in 150-mmdishes. Some 7 mg of pAAV-RC2/9 (AAV2 inverted terminal repeat (ITR) vectors
pseudo-typedwith AAV9 capsid) plasmid, 21 mg of pAAV-helper plasmid, and 7 mg of pAAV2 plasmid (carrying siRNAs againstmouse
TRPV2 to TRPV4) were added to 4 mL of DMEM without phenol red (Gibco, cat. 21063), followed by mixing with 175 mL of polyethy-
lenimine (PEI) solution (1 mg/mL, pH 7.5). The mixture was then incubated at room temperature for 20 min, and then added to the
dishes. 60 hr post transfection, cells were harvested by scraping and centrifugation. The viral particles were purified from the pellet
by an Optiprep gradient as described previously (Grieger et al., 2006). Purified AAV was titered by real-time qPCR (RT-qPCR), and
then stored at - 80C.
AAV was delivered to 6 week old male TRPV1-/- mice intravenously via lateral tail vein injection. For each mouse, 13 1011 particles
of virus, adjusted to 200 mL final volume (with PBS, pH7.4), was injected. Four weeks post injection, liver tissues were dissected and
analysis for AMPK activation.
Plasmids
Point mutations of human ALDOA, mouse TRPV1 and human TRPV4 were performed by a PCR-based site-directed mutagenesis
method using PrimeSTAR HS polymerase (Takara). Expression plasmids for various proteins were constructed in the pcDNA3.3
vector for transient transfection, in pBOBI for lentivirus packaging (stable expression), or in pLVX-IRES for doxycycline-inducible
expression. PCR products were verified by sequencing (Invitrogen, China). The lentivirus-based vector pLL3.7 was used for expres-
sion of siRNA in HEK293T and mouse embryonic fibroblasts (MEFs), and the AAV-based vector pAAV2 for mouse liver.
Cell Culture, Transient Transfection and Lentivirus Infection
HEK293T, AD293 (Adeno-X 293) cells and MEFs were maintained in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum (FBS), 100 IU penicillin, 100 mg/mL streptomycin at 37C in a humidified incubator containing 5% CO2. PEI at a
final concentration of 10 mM was used to transfect HEK293T cells. Total DNA for each plate was adjusted to the same amount by
using relevant empty vector. Transfected cells were harvested at 24 hr after transfection. Lentivirus for infection of MEFs was pack-
aged in HEK293T cells by transfection using Lipofectamine 2000. At 30 hr post transfection, mediumwas collected and added to the
cells. The cells were incubated for another 24 hr. Adenovirus was propagated in AD293 cells and purified by cesium chloride density
gradient ultracentrifugation. LAMTOR1F/F, and CaMKK2-/- MEFs were established by introducing SV40 T antigen into primary
cultured embryonic cells from a litter of corresponding mice. LAMTOR1-/- MEFs were generated by infecting LAMTOR1F/F MEFs
with adenoviruses expressing the Cre recombinase for 12 hr. The infected cells were then incubated in the fresh DMEM for another
8 to 10 hr before further treatments. Cells were verified to be free of mycoplasma contamination and authenticated by STR
sequencing. ALDO-TKD MEFs were generated and validated as described previously (Zhang et al., 2017). In brief, MEFs carrying
doxycycline-inducible expression of ALDOA-C (infected with lentivirus packaged with pLVX-IRES-ALDOA, pLVX-IRES-ALDOB
and pLVX-IRES-ALDOC) were cultured in medium containing doxycycline (Dox, 100 ng/mL), and were infected with lentiviruse6 Cell Metabolism 30, 508–524.e1–e12, September 3, 2019
expressing siRNA against ALDOA, ALDOB and ALDOC sequentially, or GFP siRNA as a control, followed by incubation in doxycy-
cline-free medium for another 12 hr. For glucose starvation, cells were rinsed twice with PBS, and then incubated in glucose-free
DMEM supplemented with 10% FBS and 1 mM sodium pyruvate for desired periods of time at 37C. For depletion of extracellular
Ca2+, cells were incubated in a solution containing all components (except CaCl2) of DMEM without phenol red (Gibco cat. 21063)
and supplemented with sodium pyruvate and 5 mM EGTA for desired time periods at 37C.
Isolation and Culture of Primary Hepatocytes
Primary hepatocytes were isolated from mice with a modified two-step perfusion method using Liver Perfusion Media and Liver
Digest Buffer. Cells were plated in collagen-coated 6-well plates in William’s medium E plus 10% FBS, 100 IU penicillin and
100 mg/mL streptomycin. After 4 hr of attachment, the medium was replaced with fresh William’s medium E with 1% BSA for further
use.
Immunoprecipitation and Immunoblotting
Endogenous LAMTOR1, TRPV4, and aldolase were immunoprecipitated and analyzed as described previously (Zhang et al., 2014)
with minor modifications. Briefly, 10 3 15 cm dishes of MEFs (grown to 80% confluence) for IP of LAMTOR1; 8 3 15 cm dishes of
MEFs (grown to 80% confluence) for IP of TRPV4 and aldolase for each gel lane were collected and lysed with 750 mL/dish of ice cold
ODG buffer [50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 1 mM EDTA (not included in assays involving Ca2+ addition), 2% ODG, 5 mM
b-mercaptoethanol with protease inhibitor cocktail], followed by sonication and centrifugation at 4C for 15 min. Cell lysates were
incubated with respective antibodies overnight. Overnight protein aggregates were pre-cleared by centrifugation at 20,000 g for
10 min, and protein A/G beads (1:250, balanced with ODG buffer) were then added into the lysate/antibody mixture for another
3 hr at 4 C. The beads were spun and washed with 100 times volume of ODG buffer for 3 times at 4 C and then mixed with an equal
volume of 23 SDS sample buffer and boiled for 10 min before immunoblotting.
For IP of ectopically expressed TRPV or aldolase, FLAG-tagged TRPV and aldolase or HA-tagged aldolase and TRPV were
co-transfected into a 10 cm-dish of HEK293T cells. After 24 hr of transfection, cells were collected and lysed in 600 mL of ice cold
ODGbuffer, followed by sonication and centrifugation at 4C for 15min. ANTI-FLAGM2Affinity Gel (1:100, balanced in ODGbuffer)
was added into the lysates and mixed for 4 hr at 4 C. The beads were washed with 200 times volume of ODG buffer for 3 times at
4 C. The FLAG tagged TRPV and aldolase were then eluted with 30 mL of FLAG Peptide (400 mg/mL final concentration) for
another 45 min at 4 C. Some 30 mL of eluent was then collected, mixed with 7.5 mL of 53 SDS buffer, and boiled for 10 min before
immunoblotting. In particular, samples containing TRPV2 were not boiled to avoid the formation of insoluble aggregates that would
fail to run into the SDS-PAGE.
To analyze the levels of p-AMPKa and p-ACC in MEFs, cells grown to 70-80% confluence in a well of a 6-well dish were lysed with
250 ml of ice cold lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium
pyrophosphate, 1mM b-glycerolphosphate, with protease inhibitor cocktail). The lysates were then centrifuged at 20,000 g for 10min
at 4C and an equal volume of 23 SDS sample buffer was added into the supernatant. To analyze the levels of p-AMPKa and p-ACC
in liver, freshly excised tissue was added with ice-cold lysis buffer (10 mL/mg liver weight), followed by homogenization and centri-
fugation as described above. The lysates were then mixed with 23 SDS sample buffer and subjected to immunoblotting. To analyze
the levels of p-AMPKa and p-ACC in nematodes, about 150 nematodes cultured on the NGMagar plate were collected for each sam-
ple. Worms were washed with ice-cold M9 buffer (22.1 mMKH2PO4, 46.9 mMNa2HPO4, 85.5mMNaCl, and 1mMMgSO4) and were
lyzed with 150 mL of ice-cold lysis buffer. The lysates were then mixed with 53 SDS sample buffer, followed by homogenization and
centrifugation as described above, and then subjected to immunoblotting. Levels of total proteins and phosphorylated proteins were
analyzed on separate gels, and representative immunoblots were shown. The band intensities on developed films were quantified
using Image J software (National Institutes of Health Freeware).
Quantification of TRPV1-6 Expression Levels by Real-time PCR
To isolate total RNA, a 10 cm-dish of MEFs or 10 mg of mouse liver were lysed in 1 mL of TRIzol reagent, followed with addition of
270 mL of chloroform and mixed vigorously. After centrifugation at 12,000 g for 15 min at 4C, 550 mL of upper aqueous layer was
transferred to a clean tube. RNA was then precipitated by adding 670 mL of isopropanol, followed with centrifugation at 12,000 g
for 10 min at 4C. The pellet was washed with 75% ethanol for 3 times by centrifugation at 7,500 g for 5 min, and was dissolved
with 30 mL of DEPC-treated water. The concentration of RNAwas then determined by a NanoDrop 2000 spectrophotometer (Thermo
Scientific). Some 5 mg of RNAwas digestedwith RQ1DNase (supplementedwith RiboLock RNase inhibitor) for 30min at 37C, and at
68C for another 10 min. The digested RNAwasmixed with random primers at 70C for 10min, and chilled on ice immediately. dNTP
and M-MLV reverse transcriptase was then added to the mixture, followed by incubation at 30C for 10 min, 42C for 1 hr, and 70C
for 15 min.
The annealing temperature of each pair of primers was first optimized according to the amplification curves, melting curves, and
bands on agarose gel of serial pilot reactions (in which a serial annealing temperature was set according to the estimated annealing
temperature of each primer pair). Here, all annealing temperatures were set at 60C. The standard curve used for quantifying the ab-
solute copy number of each TRPVwas then generated by using serial dilutions of pcDNA3.3 plasmids containing cDNA of each TRPV
(as a template), during which the optimal threshold was set automatically. The correlation coefficient (R2) of each standard curve was
calculated. Here, all R2 values were larger than 0.99. The absolute copy number of each TRPV was then determined according to theCell Metabolism 30, 508–524.e1–e12, September 3, 2019 e7
standard curves generated from the same assay plate. In experiments described above, GoTaq 1-step RT-qPCR enzyme mix was
used for amplifying targets; the StepOnePlus system and StepOne software version 2.3 (Applied Biosystems) were used for perform-
ing PCR assays and data processing.
Confocal Microscopy
For fixed cell samples, the slides were fixed for 20 min with 4% formaldehyde in phosphate-buffered saline (PBS) at room temper-
ature. The slides were rinsed twice with PBS and cells were permeabilized with 0.05% Triton X-100 in PBS (except for staining AXIN
with 0.1% Triton X-100) for 5 min at 4C. After rinsing twice with PBS, the slides were incubated with primary antibody diluted in PBS
overnight at 4C. Here, goat anti-AXIN, rabbit anti-ATP6V1B1 +ATP6V1B2, anti-mTOR, rabbit anti-T7 tag,mouse anti-ATP6v0d1 and
rat anti-LAMP2 were used, as described in the corresponding legend to specific figures. The cells were then rinsed three times with
1 mL of PBS, and then incubated with secondary antibody for 8 hr at room temperature in the dark. The Alexa Fluor 405 goat anti-
rabbit IgG, Alexa Fluor 488 donkey anti-goat IgG, Alexa Fluor 488 donkey anti-mouse IgG, Alexa Fluor 488 donkey anti-rabbit IgG,
Alexa Fluor 568 donkey anti-mouse IgG, Alexa Fluor 568 donkey anti-goat IgG, Alexa Fluor 594 donkey anti-rat IgG, Alexa Fluor 594
donkey anti-rabbit IgG, and Alexa Fluor 594 donkey anti-goat IgG antibodies were used, as described in the corresponding legends.
Cells were washed for another 4 times with 1 mL of PBS, and then mounted on slides using ProLong Diamond Antifade Mountant.
Confocal microscopic images were taken on a Zeiss Laser Scanning Microscope (LSM) 780 with a 633 1.4 NA oil objective.
For detecting the pH of lysosomes, MEFswere grown on 35mmof glass-bottom dishes, andwere cultured to 60–80%confluence.
Cells were treated with 1 mM (final concentration) LysoSensorGreen DND-189 for 1 hr, then washed twice with PBS and incubated
in fresh, desired medium for another 30 min. In the meantime, 2 mg/mL (final concentration) Hoechst was added into the medium for
staining nucleus before taking images. For detecting the cytosolic pH, MEFs were incubated with 10 mM (final concentration)
SNARF-5F in serum-free DMEM for 0.5 hr, washed twice with PBS and then switched to glucose-free DMEM containing 10%
FBS. For recording the signals of Fluo-3 in real time, cells were loaded with 5 mM (final concentration) Fluo-3-AM for 30 min, then
washed twice with PBS and incubated in fresh, desired medium for another 30 min. Before image taking, ProLong Live Antifade
Reagent was added to the medium. MEFs expressing GCaMP6s-fused protein were directly imaged after adding ProLong Live
Antifade Reagent to the medium. During imaging, live cells were kept at 37C, 5% CO2 in a humidified incubation chamber (ZEISS,
Incubator PM S1). Images were taken on a Zeiss LSM 780 with a 633 1.4 NA oil objective at regular intervals. The objective lens was
automatically focused at every 30 s.
In experiments described above, fluorescent dye Alexa Fluor 405 and Hoechst were excited with a Diode laser using a 405-nm
laser line; Lysosensor, Fluo-3, GCaMP6S, SNARF-5F and Alexa 488 with an Ar gas laser (laser module LGK 7812) using a
488-nm laser line; Alexa 568 with a DP Solid State laser (YLK6120T) using a 561-nm laser line; Alexa 594 with a HeNe gas laser
(LGK 7512 PF) using a 594-nm laser line; and Alexa 647 with a HeNe gas laser (LGK 7628-1F) using a 633-nm laser line. The param-
eters, including ‘PMT voltage’, ‘Offset’, ‘Pinhole’ and ‘Gain’, were kept unchanged between each picture taken. The resolution of
image is 1,024 3 1,024 pixels.
For imaging endogenous ER-localized TRPV4, the Semi-intact IF protocol (Du et al., 2016) was used.MEFswere grown on a 35mm
dish (In Vitro Scientific, cat. D35-20-10-N) to 50-60% confluence. Cells were rinsed with PBS once, and treated with Buffer I (25 mM
HEPES, pH 7.2, 125mMpotassium acetate, 5 mMmagnesium acetate, 1 mMDTT, 1 mg/L glucose and 25 mg/mL digitonin) for 2 min
on ice, and then Buffer II (25 mM HEPES, pH 7.2, 125 mM potassium acetate, 5 mM magnesium acetate, 1 mM DTT and 1 mg/L
glucose) for another 15 min on ice. The cells were then treated with 4% formaldehyde in PBS at room temperature for 10 min.
The slideswere rinsed twicewith PBS and cells were then permeabilizedwith 0.05%Triton X-100 in PBS for 5min at 4C. After rinsing
twice with PBS, the slides were blocked in Block Buffer (10% FBS in PBS, with 0.1% saponin) for 30 min. The slides were washed
twice with PBS and incubated with primary antibodies (goat anti-TRPV4 and rat anti-LAMP2) diluted in Block Buffer overnight at 4C.
The cells were then rinsed three timeswith PBS, and then incubatedwith secondary antibodies (Alexa Fluor 488 donkey anti-goat IgG
and Alexa Fluor 594 donkey anti-rat IgG) for another 8 hr at 4C in the dark, followed by washing for four times with PBS and then
mounted on slides using ProLong Diamond Antifade Mountant. The slides were imaged on a Zeiss Laser Scanning Microscope
(LSM) 880 using an AiryScan detector. The fluorescent dye Alexa Fluor 488 was excited with a Diode laser using a 488-nm laser
line, and Alexa Fluor 640 with a Diode laser using a 640-nm laser line. Images were processed in AiryScan mode on Zen 2012
software. The resolution of images is 2,312 3 2,312 pixels.
3D-SIM Imaging
MEFs stably expressing HA-TRPV4 were grown in a 35-mm dish (In Vitro Scientific, cat. D35-20-10-N) to 50-60% confluence, and
were treated following the Semi-intact IF protocol as described above, except that the cells were incubated in rabbit anti-HA tag and
rat anti-LAMP2 primary antibodies, and then with Alexa Fluor 488 donkey anti-rabbit IgG and Alexa Fluor 568 goat anti-rat IgG sec-
ondary antibodies. Images were acquired using a UPlanSApochromat 1003 1.4NA, oil immersion objective lens (Olympus) and a
back-illuminated Cascade II 512 3 512 electron-multiplying charge-coupled device (EMCCD) camera (Photometrics) on an OMX
version 2 system (Applied Precision) equipped with 405-, 488-, 561-, and 647 nm solid-state lasers. Immersion oil of refractive index
1.1515 was used, after being empirically determined to give the most symmetric point spread function. Samples were illuminated by
a coherent scrambled laser light source that had passed through a diffraction grating to generate the structured illumination by inter-
ference of light orders in the image plane to create a 3D sinusoidal pattern, with lateral stripes approximately 0.2 mmapart. The pattern
was shifted laterally through five phases and through three angular rotations of 60 for each Z-section, separated by 0.125 mm, ande8 Cell Metabolism 30, 508–524.e1–e12, September 3, 2019
the range of z-stack was 3 mm. The power of each laser was adjusted to achieve optimal intensities of between 2,000 and
4,000 counts in a raw image of 16-bit dynamic range, at the lowest possible laser power to minimize photo bleaching. Each frame
acquisition was separated by a 300-ms pause. Raw images were processed and reconstructed as described previously (Schermel-
leh et al., 2008). The channels were then aligned in x, y, and rotationally using predetermined shifts as measured using a target lens
and the Softworx alignment tool (Applied Precision). The images were further processed in OMX system (Applied Precision).
STORM Imaging
MEFs stably expressing HA-TRPV4 and Myc-LAMP2 were cultured in the Lab-TekII chambered #1.5 German Coverglass System
(NUNC, 155409, 8 Chamber) to 50% confluence, and were treated following the Semi-intact IF protocol as described above, except
that the cells were incubated in rabbit anti-HA tag primary antibody and mouse anti-Myc tag primary antibody, and then with the Atto
488 goat anti-rabbit IgG and Alexa-Fluor 647 donkey anti-mouse IgG secondary antibodies. The slides were then fixed with 4% form-
aldehyde for another 10 min, and washed twice with PBS. The STORM Imaging Buffer with MEA was then prepared according to the
manufacturer’s instructions. Briefly, 7 mL of GLOX (14mg of glucose oxidase, 50 mL catalyze (17mg/mL), 200 mL Buffer A (10mMTris,
pH 8.0, and 50 mMNaCl), vortexed to dissolve and cooled on ice) and 70 mL 1 MMEA (77 mgMEA dissolved in 1.0 mL of 0.25 N HCl)
were added to 620 mL Buffer B (50 mM Tris, pH 8.0, 10 mM NaCl and 10% (m/v) glucose) in a 1.5 mL Eppendorf tube, followed by
gentle vortex. Themixture was then added to eachwell, and images were taken on an N-STORM (Nikon). The imaging was performed
using an inverted microscope system (Ti-E Perfect Focus; Nikon) equipped with a monolithic laser combiner (MLC400, Agilent Tech-
nologies) containing solid-state lasers of wavelengths 405 nm, 488 nm, and 561 nm at 50 mW (maximum fiber output power) and a
647-nm laser at 125 mW. After locating a suitable field, a diffraction-limited TIRF image was acquired for reference, followed by a
STORM acquisition. The 647-nm laser was then sequentially fired at 100% power to excite all possible fluorophore molecules and
photoswitch them into a nonemitting dark state, and then the 488-nm laser. The emitted wavelengths from Alexa Fluor 647 and
Atto 488 fluorophoreswere then sequentially collected by the plan-Apochromat 1003/1.49 TIRF objective (Nikon), filtered by an emis-
sion filter set (Nikon TIRF Cube consisting of a TRF89902-EM filter set, Chroma Technology), and detected on an electron-multiplying
charge-coupled device camera (Ixon DU-897, Andor Technology). During imaging, 20,000 sequential frames of each channel were
acquired. The image acquisition, lateral drift correction, and data processing were performed by using NIS Elements software with
STORM package (version 4.30 build 1053, Nikon) as described previously (Dempsey et al., 2011; Jones et al., 2011).
Intracellular Calcium Measurement by Fura-2-AM
Briefly, MEFs were cultured to 80-90% confluence in a black, clear-bottom 96-well assay plate (Corning, cat. 3603). Cells were
cultured in DMEM without phenol red supplemented with sodium pyruvate, then loaded with 5 mM (final concentration, pre-mixed
with the Pluronic F-127 stock solution at a ratio of 1:1) Fura-2-AM for 1 hr. The unloaded Fura-2-AM was then removed by two times
of PBS rinsing, and the cells were further incubated in DMEMwithout phenol red (supplemented with sodium pyruvate) for 0.5 hr. The
average concentrations of intracellular calcium, [Ca2+]i, were then determined according to the fluorescent intensities of Fura-2
excited at 340 nm (Fl1, represents Ca
2+ bound-state) and 380 nm (Fl2, represents Ca
2+ unbound-state), respectively (recorded
by a SpectraMax M5 microplate reader from Molecular Device):

Ca2+

i=KdQ
ðR RminÞ
ðRmax  RÞ ;
where R represents the ratio of 510-nm emission intensity, i.e., Fl1/Fl2, of Fura-2, and the values of Rmin, Rmax Q and Kd (for Fura-2)
were obtained by a in situ calibration assay (Petr and Wurster, 1997).
This assay was also used for correcting background fluorescence of the Fura-2 indicator. Briefly, a series of solutions containing
different concentrations of calcium ions were first prepared by diluting the CaEGTA stock solution at 37C, pH 7.2, mimicking the
in vivo situation. The solution, along with 10 mM ionomycin, was then added to the Fura-2-loaded MEFs. Following the measurement
of the Fl1 and Fl2 of Fura-2, cells were incubated for an additional 20 min with 6 mM MnCl2 to quench the fluorescence of the indi-
cator. The remaining fluorescence was considered as background fluorescence, which was subtracted from the total fluorescence,
afterwards. The difference between the total fluorescence and the background fluorescence was considered as the actual cytosolic
fluorescence. The corrected values of Fl1 were increased proportionally to the increase of Ca
2+ concentrations in CaEGTA solutions,
while the corrected values of Fl2 were changed independent of Ca
2+ concentrations. The value of Rmin, was generated from the cor-
rected Fl1/Fl2 ratio at zero free Ca
2+, andRmax from 27.96 mM (saturating) Ca
2+. Q value was determined by the ratio of Fl2 at zero free
Ca2+, to Fl2 at 27.96 mM freeCa
2+. A series values of log ½ðRRminÞ=ðRmax RÞ3Q, generated from each solution, were then plotted
with the log value of its free Ca2+ concentration. After that, a straight line was yielded, and a linear regression equation: y = 1.2956x +
8.7237 (R2 = 0.935), was generated. The log of Kd was determined according to the x-intercept of this straight line. We determined
that the Kd for Fura-2 is 184.7872 nM.
Purification of Lysosomes
Lysosomes were purified by Lysosome Isolation Kit according to the manufacturer’s instructions, with minor modifications.
Briefly, MEFs from sixty 10-cm dishes (60-80% confluence) were collected by directly scrapping at room temperature, followed
by centrifugation for 5 min at 500 g at 37C. Cells were resuspend in 7 mL of 13 Extraction Buffer containing protease inhibitor cock-
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centrifuging for 10min at 1,000 g, 4C, yielding post-nuclear supernatants (PNS). The PNSwere then centrifuged for 20min at 20,000
g and the pellet was suspended by 13 Extraction Buffer by gentle pipetting, generating Crude Lysosomal Fraction (CLF). The volume
of CLF was adjusted to 2.4 mL and then equally divided into six 1.5 mL Eppendorf tubes (400 ml per tube). 253 mL of OptiPrep and
137 mL of 13 OptiPrep Dilution Buffer were added to each CLF, and mixed by gentle pipetting. The mixture is defined as the Diluted
OptiPrep Fraction (DOF). Each DOF (0.8 mL) was loaded to an 11 3 60 mm centrifuge tube at the top of 27% (0.4 mL) and 22.5%
(0.5 mL) OptiPrep solution cushions, and then overlaid with 16% (1 mL), 12% (0.9 mL) and 8% (0.3 mL) OptiPrep solutions. The
tube was then centrifuged on a SW60 Ti rotor (Beckman) at 150,000 g for 4 hr at 4C, and the fraction at the top of 12% OptiPrep
solution was collected as the crude lysosome fraction. The fraction was diluted with two volumes of PBS, followed by centrifugation
at 20,000 g for 20 min. The supernatant was then aspirated, and the sediment was the lysosome fraction.
Measurement of v-ATPase Activity In Vitro
For each assay, lysosomes purified from two 10-cm dishes of MEFs were used. ATP hydrolysis activity was measured using a
coupled spectrophotometric method as described previously (Shao and Forgac, 2004) with some modifications. Briefly, lysosomes
were suspended in ATPase assay buffer (50mMNaCl, 30mMKCl, 20mMHEPES-NaOH, pH 7.0, 10%glycerol, 1mMMgCl2, 1.5mM
phosphoenolpyruvate, 0.35 mM NADH, 20 U/mL pyruvate kinase, and 10 U/mL lactate dehydrogenase) with 5 mM ConA (for calcu-
lating the v-ATPase-specific ATP hydrolysis activity) or DMSO, and warmed at 37C for 10 min. The assay was initiated by the
addition of 5 mM ATP, and the OD341 was continuously recorded by a SpectraMax M5 microplate reader.
ATP-dependent proton transport activity was measured by the initial rate of ATP-dependent fluorescent quenching of FITC-
dextran, as described previously (Liberman et al., 2014; Trombetta et al., 2003). Briefly, lysosomes were loaded with FITC-dextran
by incubating cells in DMEM supplemented with 2 mg/mL FITC-dextran (final concentration) on ice for 5 min, then transferred to a
37C incubator for 30 min. Cells were washed with DMEM for three times and incubated with DMEM for another 30 min at 37C to
allow transport of FITC-dextran to lysosomes. Cells were collected and lysosomes were purified as described above. The lysosomes
were resuspended in assay buffer (125 mM KCl, 1 mM EDTA, 20 mM HEPES, pH 7.5, with KOH) and were balanced on ice for 1 hr,
then mixed with 5 mM ConA (for calculating the v-ATPase-specific proton transport activity) or DMSO, then warmed at 37C for
10 min. Fluorescence of FITC was recorded with excitation at 490 nm and emission at 520 nm using a SpectraMax M5 microplate
reader. The initial slope of fluorescence quenching was measured after addition of 5 mM Mg-ATP (final concentration).
Isolation of Light Organelles
Light organelles were isolated as described previously (Steinberg et al., 2010; Zoncu et al., 2011). Briefly, cells were scraped and
spun down at 200 g at room temperature, and then resuspended in 750 mL per 15-cm dish of fractionation buffer (140 mM KCl,
1 mM EGTA, 5 mM MgCl2, 50 mM sucrose, 20 mM HEPES, pH 7.4, supplemented with 2.5 mM ATP, amino acids and protease
inhibitor cocktail) at room temperature, and were mechanically broken by spraying 6 times through a 22G needle, yielding PNS after
spinning at 2,000 g for 5 min. The PNSwas then spun at max speed for 15min in a tabletop centrifuge. The pellets are light organelles
and supernatants are the cytosol.
In Vitro Reconstitution for Lysosomal Binding Assays
Light organelles then re-suspended with 100 mL fractionation buffer containing 10 mM FBP were incubated at 37C in a thermomixer
at 400 rpm for 15 min. Some 500 mL of cytosol was then added to the mixture, followed by incubation at 37C for another 25 min. The
mixtures were lysed with 800 mL ODG buffer, followed by IP with antibody against LAMTOR1.
Purification of ER
Method for isolating pure ER was optimized by combining the traditional microsome-based density gradient isolation method
(Endoplasmic Reticulum Isolation Kit developed by Sigma-Aldrich) with the cell surface biotinylation reaction method (developed
and optimized by Pierce). Briefly, MEFs from 40 10-cm dishes (80% confluence) were quickly washed with ice-cold PBS (10 mL
each dish) twice, followed by incubating with 250 mg/mL of sulfo-NHS-SS-biotin (freshly dissolved in ice-cold PBS, 10 mL each
dish) for 30 min with gentle agitate on an orbital shaker at 4C. Some 500 mL of 1 M Tris (pH 8.0 at 4C) was then added to each
dish to quench the biotinylation reaction. Cells were collected afterwards by directly scrapping, followed by centrifugation at
600 g for 5 min, and then washed with 40 mL of ice-cold PBS twice. Cells were then re-suspended in 10 mL of 13 Hypotonic Extrac-
tion Buffer and then incubated at 4C for 30min, with gentlemixing in themiddle. Cells were then centrifuged at 600 g at 4C for 5min,
and the pellet was re-suspended with 6mL of 13 Isotonic Extraction Buffer, followed bymixing in a 7-mLDounce homogenizer for 10
strokes. The homogenate was centrifuged at 1,000 g for 10min at 4C, and the supernatant (PNS) was further centrifuged at 12,000 g
for 15 min at 4C, yielding the supernatant as the post-mitochondrial fraction (PMF). The PMF was loaded in two 113 60 mm centri-
fuge tubes and then centrifuged on an SW60 Ti rotor (Beckman) at 100,000 g for 1 hr at 4C. The pellet was re-suspended with 0.5mL
of 13 Isotonic Extraction Buffer, and was mixed in a 2-mL Dounce homogenizer for 20 strokes, yielding the microsomal suspension.
The suspension was mixed with 0.25 mL of OptiPrep, and was carefully layered on the top of 1 mL of 30%OptiPrep solution (by mix-
ing 0.5 mL of OptiPrep with 0.5 mL of 13 Isotonic Extraction Buffer) in an 113 60 mm centrifuge tube. Some 2 mL of 15% OptiPrep
solution (by mixing 0.5 mL of OptiPrep with 1.5 mL of 13 Isotonic Extraction Buffer) was then carefully layered on the top of the
sample. The tube was then centrifuged on an SW60 Ti rotor at 150,000 g for 3 hr at 4C. The top 0.6 mL of 15% OptiPrep solution
was discarded, and the following 200 mL of fraction was collected as the crude ER fraction. The fraction was then incubated withe10 Cell Metabolism 30, 508–524.e1–e12, September 3, 2019
100 mL of NeutrAvidin Agarose (pre-balanced by 13 Isotonic Extraction Buffer) for another 2 hr. The supernatant was thenmixed with
50 mL of 53 SDS sample buffer for immunoblotting analysis.
Protein Production
Full length cDNAs encoding calmodulin and CaMKK2 were cloned into pET-28a (Novagen) and pGEX4T-1 (GE Healthcare) vectors,
respectively, and transformed into the E. coli strain BL21 (DE3). The transformed cells were induced with 0.1 mM IPTG at an optical
density of 1.0 at 600 nm. After incubating for another 4 hr at 30C, the cells were collected. For His-tagged calmodulin, cells were
homogenized in a His binding buffer (50 mM sodium phosphate, pH 7.4, 150 mM NaCl, 1% Triton X-100, 5% glycerol, and
10 mM imidazole), and for GST-tagged CaMKK2, with a GST binding buffer (PBS supplemented with 10 mM b-mercaptoethanol
and 1% Triton X-100). The homogenates were then sonicated, and were subjected to ultracentrifugation at 150,000 g for 30 min,
followed by purification of calmodulin with Nickel Affinity Gel or CaMKK2 with Glutathione Sepharose 4 Fast Flow Gel. The Nickel
Affinity Gel was then washed with 100 times the volume of His wash buffer (50 mM sodium phosphate, pH 7.4, 150 mM NaCl,
and 20 mM imidazole), and the Glutathione Sepharose gel with 100 times the volume of PBS. Calmodulin was eluted from the resin
by His elution buffer (50 mM sodium phosphate, pH 7.4, 150 mM NaCl, and 250 mM imidazole), and CaMKK2 was eluted by GST
elution buffer (50 mM Tris–HCl, pH 8.0, and 10 mM reduced glutathione). Proteins were concentrated to approximately 3 mg/mL
by ultrafiltration (Millipore, UFC905096 for CaMKK2, and UFC901096 for calmodulin), then subjected to a gel filtration column
(GE Healthcare, Superdex-200) balanced with an AMPK kinase assay buffer containing 50 mM MOPS, pH 7.0, 100 mM NaCl,
0.1 mM EDTA, and 10 mM MgCl2. Heterotrimeric AMPK was expressed in the E. coli strain BL21 (DE3) as described previously
(Neumann et al., 2003) and purified through a gel filtration column as described above.
Kinetic Analysis of CaMKK2 Activity
The enzymatic activity of CaMKK2 was expressed by the activity of AMPK pre-phosphorylated by CaMKK2. The assay was per-
formed as described previously (Chen et al., 2009) withminor modifications. Briefly, GST-tagged CaMKK2was incubated with Gluta-
thione Sepharose 4 Fast Flow Gel (5 mg of protein/mL gel) at 4C for 1 hr, followed by washing in an AMPK kinase assay buffer twice.
Some 1 mL of immobilized CaMKK2 was then incubated with 5 mg of AMPK, 10 mg of calmodulin in AMPK kinase assay buffer sup-
plemented with 5 mM ATP and desired concentrations of CaCl2 (total volume: 60 mL) on a thermomixer at 30
C for 30 min. CaMKK2
was then removed by centrifugation at 2,000 g, 4C for 30 s, resulting in the supernatant that contained phosphorylated AMPK.
Activity of the resultant AMPKwas determined by incubating 50 mL of the supernatant with 200 mL of 30C-pre-warmed AMPK kinase
assay buffer supplemented with 0.2 mM NADH, 1.0 mM phosphoenolpyruvate, 20 U/mL lactate dehydrogenase, 15 U/mL pyruvate
kinase, 5 mM ATP and 200 mM ACC tide (HMRSSMSGLHLVRRR, synthesized by GenScript, China) at 30C. The OD341 was contin-
uously recorded by a SpectraMax M5 microplate reader.
Analysis of AMP/ATP and ADP/ATP Ratios
To analyze AMP/ATP and ADP/ATP ratios in mammalian cell lines, mouse liver and muscle, CE (capillary electrophoresis)-MS was
performed. Sample preparation for CE-MS was carried out as described previously (Zhao et al., 2014; Zhao et al., 2015), with some
modifications. In general, each measurement requires cells collected from a 10-cm dish (60-70% confluence) or 20 mg of freeze-
clamped mouse liver. Cells/tissues were rinsed with 20 mL of 5% mannitol solution (dissolved in water) and instantly frozen in liquid
nitrogen. Cells/tissues were then lyzed with 1 mL of methanol containing internal standards 1 (IS1 used to standardize the metabolite
intensity and to adjust the migration time), and cells were scrapped off from the dish. Lysate was then mixed with 1 mL of chloroform
and 400 mL of water by 20 s of vortexing. After centrifugation at 15,000 g for another 15 min at 4C, 450 mL of aqueous phase was
collected and was filtrated through a 5 kDa cutoff filter (Millipore, cat. UFC3LCCNB-HMT) by centrifuging at 10,000 g for 3 hr at 4C.
The filtered aqueous phase was then freeze-dried in a vacuum concentrator (Labconco, CentriVap Benchtop Centrifugal Vacuum
Concentrator, equippedwith a CentriVap -84CCold Trap and a Scroll VacuumPump) and then dissolved in water containing internal
standards 3 (IS3 to adjust themigration time). 20 mL of re-dissolved solution was then loaded into an injection vial with a conical insert
for CE-TOF MS (Agilent Technologies 7100, equipped with 6224 mass spectrometer) analysis. Data were processed using Qualita-
tive Analysis B.06.00. Levels of AMP, ADP, and ATP were measured using full scan mode with m/z 346.0558, 426.0221, and
505.9885, respectively. Note that a portion of ADP and ATP could lose one phosphate group during in-source-fragmentation thus
leaving same m/z ratios as AMP and ADP, and should be corrected according to their different retention time in capillary. Therefore,
the total amount of ADP is the sum of the latter peak of the m/z 346.0558 spectrogram and the former peak of the m/z 426.0221
spectrogram, and ditto for ATP.
Measurement of NAD+
To measure NAD+ levels in muscle, some 50 mg of fleshly excised gastrocnemius muscle was immediately frozen in liquid nitrogen
and homogenized in 1 mL of ice-cold methanol. Some 1 mL of chloroform and 400 mL of water were then added to the homogenate
sequentially, followed by 20 s of vortexing. After centrifugation at 15,000 g for 15min at 4C, 350 mL of aqueous phase was collected,
lyophilized in a vacuum concentrator, and then dissolved in 500 mL of 20% methanol. The remaining solution was dried at a fume
hood at room temperature for three days to obtain the dry weight of protein (for calculating the relative concentrations of NAD+).
Measurement of NAD+ level was based on (Katsyuba et al., 2018) using a QTRAP MS (SCIEX, QTRAP 6500 plus) interfaced with
a UPLC system (Waters, ACQUITY UPLC system) with minor modifications. In brief, 2 mL of each sample was loaded onto a SeQuantCell Metabolism 30, 508–524.e1–e12, September 3, 2019 e11
ZIC-pHILIC column (5 mm, 1003 2.1 mm,Merck). Mobile phase buffer A was 15 mM ammonium acetate in water (pH adjusted to 9.7
with ammonium hydroxide), andmobile phase buffer B 90%acetonitrile. During the analysis, the columnwasmaintained at 40C and
sample at 8C. The gradients were as follows: t = 0-2 min, 95% B; t = 15-18 min, 45% B; t = 18-22 min, 95% B, with a constant flow
rate at 0.2 mL/min. The QTRAP mass spectrometer was run in negative mode with multiple reactions monitoring mode (MRM), and
declustering potentials and collision energies were optimized using analytical standards of NAD+. The following transition was used
for monitoring NAD+: 662.0/540.1. The retention time of NAD+ was 10.3 min.
Determination of Lysosomal Membrane Potential
To measure FRET in MEFs, cells were first loaded with Rhodamine-PE (Rh-PE, FRET acceptor) followed by addition of the mem-
brane-permeant oxonol dye DiBAC4(3) (FRET donor) to the culture medium. The emission intensities of the donor, acceptor and
FRET channels were separately measured according to the images taken by a Zeiss LSM 780. The bleed-through parameters of
donor and acceptor were then calculated according to the values of cFRET as described previously (Koivusalo et al., 2011). Briefly,
Rh-PE was freshly prepared by adding 25 mL of 1 mg/mL Rh-PE solution in CHCl3/MeOH (1:1) dropwise into 4 mL of 0.5 mg/mL fatty
acid-free BSA in PBS accompanied with vigorously vortexing for 1-2 min. MEFs grown in 35-mm glass bottom dishes were washed
with ice-cold PBS, and incubated with the Rh-PE-BSA complex for 10 min on ice to allow for the entry of this complex into the cell.
Cells were then washed with medium, and incubated at 37C for another 90 min. A 300 nM DiBAC4(3) was added to the medium and
the cells were balanced for 5 min at 37C, then washed and imaged in the live-cell incubation chamber at a regular interval. Different
fields of the donor, acceptor and FRET channels were first acquired, and the filter set parameters (listed as excitation/emission filters,
all in nanometers ± bandwidth) used for FRET calculation were as follows: donor DiBAC4(3) at 475 ± 60/510 ± 40, acceptor Rh-PE at
543 ± 22/580 ± 25, and FRET at 475 ± 60/580 ± 25. For the determination of the donor and acceptor bleed-through coefficients,
samples loaded with donor or acceptor only were imaged. Cells loaded with donor alone, showed negligible cFRET signal. Similarly,
cFRETwas virtually absent when only the acceptor was present. InMEFs that had been loadedwith both the donor and the acceptor,
the cFRET signal was detectable and recorded, andwas calculated using themethod as described previously (Koivusalo et al., 2011).
All parameters, including exposure times and camera gains, were kept constant across each experiment. Images were background-
subtracted before analysis.
QUANTIFICATION AND STATISTICAL ANALYSIS
1-way or 2-way ANOVA with post hoc analysis was used to compare values among different experimental groups. For experiments
with only two groups, a two-tailed Student’s t test was used as specified in the figure legends. For ANOVA, the homogeneity of vari-
ance was tested by Levene’s test. If the results are similar, the Tukey’s test was preceded, and if not, the Games-Howell’s test was
preceded. Similar procedures were followed when Student’s t test was performed. No samples or animals were excluded from the
analysis. Tests were performed with SPSS Statistics 17.0 program or Prism 6, and p < 0.05 was considered statistically significant.
Statistical significance is shown as * p < 0.05, ** p < 0.01, *** p < 0.001; N.S., not significant.
DATA AND SOFTWARE AVAILABILITY
All software and data used are freely available either online through various servers (see Key Resources Table). Source data for blot
quantification can be found in Mendeley Data: https://data.mendeley.com/datasets/p3zgm58ksw/draft?a=10c923e7-0295-4f9c-
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